criterion_id,criterion_text,patient_0001,patient_0002,patient_0003,patient_0004,patient_0005,patient_0006,patient_0007
critere_0001,"""secondary"" ICH: ICH resulting from intracranial vascular malformation, intracranial venous thrombosis, head trauma or tumour; haemorrhagic transformation within an infarct",true,false,unknown,true,true,true,false
critere_0002,"(a) T1DM at Screening Visit: (i) For US only: patients with T1DM treated with SGLT2i for at least 4 months, without DKA during that period, and who have experience with ketone monitoring are eligible for inclusion.",unknown,false,unknown,unknown,true,unknown,false
critere_0003,(b) Uncontrolled T2DM at screening: HbA1C \> 10.5% (\> 91 mmol/mol).,unknown,false,unknown,unknown,unknown,false,false
critere_0004,"(ii) For Japan only: patients with T1DM treated with dapagliflozin 10 mg for at least 4 months, without DKA during the period of dapagliflozin treatment are eligible for inclusion.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0005,"\* patients may enrol during the first 6 months of standard endocrine therapy, and wait until at least 6 months of endocrine therapy has been received prior to starting ctDNA surveillance",unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0006,"≤ MAS \< 4 on elbow or wrist flexors,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0007,≥ 18 and ≤ 55 years for phase I,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0008,≥ 18 and ≤ 60 years for phase II.,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0009,a head size incompatible with the use of a personalized 3D headcast or a magnetoencephalography,unknown,false,unknown,unknown,unknown,unknown,false
critere_0010,A history of stroke or recent trauma to the head,true,false,unknown,true,true,unknown,false
critere_0011,"A pacemaker, insulin or other pump, neurostimulator, cochlear implants or other hearing aid, metal stents, prosthesis, or implants, intracerebral clips, implantable defibrillator, cerebral shunt or ventricular catheter, other foreign metal objects in the upper part of the body",unknown,false,unknown,unknown,unknown,unknown,false
critere_0012,A piercing or obstruction in the nostrils that could impede vaccine administration.,true,false,true,true,true,true,false
critere_0013,"Able to follow a rehabilitation program on medical opinion (no medical issues or acute intercurrent medical events),",true,true,true,true,true,true,true
critere_0014,Able to swallow tablets,unknown,false,unknown,unknown,true,unknown,true
critere_0015,Able to understand and voluntarily sign a written informed consent before any screening procedures.,false,false,false,false,false,false,true
critere_0016,"Able to understand, read, and write French,",true,false,true,true,true,true,true
critere_0017,"Abnormal and deemed clinically significant result by the investigator following the routine analyzes carried out at the time of the screening visit (any grade 4 biological result, even if deemed not clinically significant by the investigator, constitutes an exclusion criterion).",true,false,true,true,true,true,false
critere_0018,Absence of health insurance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0019,"Absence of hepatocellular carcinoma outside at least one nodule \&gt; 3 cm in diameter, or more than 3 nodules, on ultrasound, CT-scan or MRI performed during the previous 6 months",true,false,true,true,true,true,false
critere_0020,Absence of metastatic disease,unknown,false,unknown,unknown,unknown,unknown,false
critere_0021,absence of pre-existing neurological handicap (mRS 0-2),true,false,unknown,false,true,unknown,false
critere_0022,"Absence of severe progressive neurologic and/or somatic pathologies (specially tumors, degenerative diseases)",true,false,true,true,true,true,false
critere_0023,"Active bleeding,",unknown,false,unknown,true,unknown,unknown,unknown
critere_0024,"Active cardiac disease or history of cardiac dysfunction, including any of the following:",unknown,false,unknown,true,unknown,unknown,false
critere_0025,active cause of cirrhosis and:,unknown,false,unknown,unknown,unknown,unknown,false
critere_0026,"Active cause of cirrhosis, or resolution (alcohol cessation, sustained virological response to direct-acting antiviral treatment for HCV, initiation of nucleoside/nucleotide analog treatment for HBV) for at least 6 months",unknown,false,true,unknown,true,unknown,false
critere_0027,"Active inflammatory bowel disease or chronic diarrhea, short bowel syndrome, or major upper gastrointestinal surgery including gastric resection.",unknown,false,unknown,true,unknown,true,false
critere_0028,"Active or uncontrolled infections (e.g., sepsis, tuberculosis, hepatitis B or hepatitis C at the screening visit, human immunodeficiency virus\[HIV\]) that could complicate participation in the study.",unknown,false,unknown,unknown,unknown,false,false
critere_0029,Active systemic bacterial or fungal infection (requiring intravenous \[IV\] antibiotics or antifungals at the time of initiating study treatment).,unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0030,acute / chronic renal insufficiency (Cl \<50ml / min),unknown,false,unknown,unknown,true,unknown,false
critere_0031,Adequate organ function,unknown,false,unknown,unknown,true,unknown,unknown
critere_0032,Administrative problems:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0033,"Admitted within 12 hours of stroke onset. For wake-up strokes, time of last seen well will be considered as stroke onset",false,false,true,true,true,unknown,false
critere_0034,"Adolescents aged 14+/- 6 months,",false,false,true,true,true,true,false
critere_0035,"Adult patient \> 18 years old,",false,false,true,true,true,true,false
critere_0036,Adult patient ≥18 years old,false,false,true,true,true,true,false
critere_0037,"Adult patient,",false,false,true,true,true,true,false
critere_0038,Adult patients,false,false,true,true,true,true,false
critere_0039,Adults who are deprived of their liberty by judicial or administrative decision,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0040,Advanced or moderate chronic kidney disease (eGFR 15 to 44.9 mL/min/1.73m² using CKD-EPI formula),unknown,false,unknown,unknown,unknown,false,false
critere_0041,Affiliated or entitled participant in a social security scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0042,Affiliated to or beneficiary of a health insurance system (including AME),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0043,Affiliated to social security,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0044,"Affiliated with a social security scheme,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0045,Affiliation of health care assurance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0046,Affiliation of the patient to a social security scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0047,Affiliation to social security,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0048,affiliation to social security or benefiting through a third person,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0049,Affiliation with or beneficiary of a social security program (health insurance),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0050,Affiliation with or beneficiary of a social security program (health insurance),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0051,Age \<18 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0052,"Age \<18 years old,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0053,Age \> 70 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0054,Age ≥ 18 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0055,Age ≥ 18 years old,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0056,Age ≥ 18 years old,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0057,Age ≥18 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0058,Age between 18 and 40 years old.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0059,Age over 18 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0060,Agree to abstain from donating blood/plasma or any other bodily fluids from the time of vaccination until 1 year after vaccination (only for LVT-001 vaccine).,unknown,false,false,unknown,unknown,false,false
critere_0061,Agree to be registered in the computerized file of the Ministry of Health (VRB).,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0062,Agree to implement barrier measures as much as possible (washing hands and wearing a mask) against COVID-19 and respiratory infections between D0 and D28.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0063,Agree to stay in the geographical area of one of the clinical sites for the duration of the trial.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0064,"Alcohol consumption \> 14 units/week for women or \> 21 units/week for men, current or abstinent for less than 6 months",unknown,false,unknown,unknown,true,unknown,true
critere_0065,Alcohol ingestion before the examination,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0066,All musculoskeletal conditions affecting the cervical spine less than 6 months old.,unknown,unknown,true,unknown,true,unknown,unknown
critere_0067,All musculoskeletal conditions affecting the upper limb less than 6 months old.,unknown,false,true,unknown,true,unknown,false
critere_0068,All participants must sign informed consent before the start of the study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0069,Allergy or hypersensitivity to cold,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0070,Allergy to any excipient known to be present in the probiotic or placebo formulation,unknown,false,unknown,unknown,unknown,unknown,false
critere_0071,Amblyopia,unknown,false,unknown,unknown,unknown,unknown,false
critere_0072,An Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 assessed within 7 days before first dose of study treatment,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0073,Anatomical anomaly of the venous sinus which would prevent safe catheterization and stenting,true,unknown,unknown,true,true,unknown,unknown
critere_0074,"Anticipated disability to attend all the visits, treatments and measures planned by the protocol: severe personality disorder, severe substance addiction, severe intellectual development disorder. In any of those cases, the notion of severity is at the indiscretion of the investigator",unknown,false,true,true,true,true,false
critere_0075,Anticipated length of hospital stay in a participating centre ≥ 5 days,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0076,Any active tumor of non-breast-cancer histology.,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0077,Any acute kidney injury within 3 months prior to the Screening Visit,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0078,Any clinical condition requiring systemic immunosuppression therapy other than stable maintenance therapy for at least 3 months prior to Visit 1.,false,false,false,false,false,false,false
critere_0079,"Any concurrent disease or serious medical condition or abnormality in clinical laboratory tests that, in the investigator's judgment, precludes the patient's safe participation in and completion of the study.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0080,"Any condition that, in the opinion of the investigator, would make the subject's participation in the study undesirable or that would compromise compliance with the protocol",true,unknown,true,true,true,true,true
critere_0081,"Any constitutional or acquired hemorrhagic disease, (including digestive hemorrhages, history of hemorrhagic stroke and thrombocytopenia",unknown,unknown,true,unknown,unknown,true,unknown
critere_0082,any dental apparatus containing metal including or root canals,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0083,Any dialysis (including for acute kidney injury) within 3 months prior to Screening Visit.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0084,any foreign metallic object anywhere in the body,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0085,Any form of contraindication to the trial vaccines tested.,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0086,"Any medical or active psychological condition or any clinically relevant laboratory abnormalities, such as, but not limited, to elevated ALT or AST (\> 3 × ULN) in combination with elevated bilirubin (\> 2 × ULN), at the screening/baseline visit.",true,true,true,true,true,true,true
critere_0087,"Any other condition or previous therapy that, in the opinion of the Investigator or their designee, would render the participant unsuitable for this study, including an inability to fully comply with the study protocol requirements or a likelihood of noncompliance with study procedures.",true,unknown,true,true,true,true,true
critere_0088,"Any other condition or previous therapy that, in the opinion of the Investigator or their designee, would render the patient unsuitable for this study, including an inability to fully comply with the study protocol requirements or a likelihood of noncompliance with study procedures.",true,unknown,true,true,true,true,true
critere_0089,"Any other condition that, in the opinion of the investigator, would compromise the safety or rights of a volunteer participating in the trial or render the subject unable to comply with the protocol.",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0090,"Any other reason which in the opinion of the investigator, could interfere with the evaluation of the study objectives.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0091,Any other serious chronic illness requiring immediate monitoring by a hospital specialist.,true,unknown,true,true,true,true,unknown
critere_0092,Any patient for whom IGB is contraindicated \[criteria defined by the French Society for Digestive Endoscopy) and the French Think-Tank for Hepato-Gastroenterology Practices\]:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0093,"Any significant co-morbidity that would impact the study or the subject's safety, including subjects with significant malabsorption.",true,unknown,true,true,true,true,unknown
critere_0094,Any tumor size (pT stage);,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0095,"Any use of mineralocorticoid receptor antagonists (such as spironolactone, eplerenone, or finerenone), potassium-sparing diuretics (such as triamterene or amiloride), or potassium binders (such as sodium zirconium cyclosilicate, patiromer, or sodium polystyrene sulfonate) within 4 weeks prior to screening.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0096,"Apparent wound, which may postpone inclusion, or very fragile skin,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0097,"Arterial hypertension treated with at least one blood pressure lowering drug therapy among blockers of the renin-angiotensin system (ACEi or ARB), at the maximal posology tolerated by the patients stable since at least one month. Other blood pressure lowering drug therapies are tolerated.",false,false,unknown,unknown,unknown,false,false
critere_0098,Asthma according to the Global Initiative for Asthma (GINA) criteria,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0099,"Asymptomatic,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0100,At least 1 or more ESR1 point mutations in the ESR1 ligand binding domain as assessed in cell- free ctDNA obtained from a blood or breast cancer tissue.,unknown,false,unknown,unknown,unknown,true,false
critere_0101,At least one of the following criteria:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0102,Autosomal dominant polycystic kidney disease treated with Tolvaptan,unknown,false,unknown,unknown,unknown,unknown,false
critere_0103,"Available tissue from one archival tumour tissue sample (either from diagnostic biopsy, primary surgery or where available residual disease post-neoadjuvant chemotherapy)",unknown,false,true,true,true,true,false
critere_0104,"B. Tumour size \> 5 cm, regardless of lymph node status, or",unknown,true,unknown,unknown,unknown,true,true
critere_0105,Be affiliated to French social security system.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0106,Be male or female between the ages of:,false,false,true,true,true,true,false
critere_0107,Be non-athletic,unknown,unknown,true,true,unknown,true,unknown
critere_0108,Be registered as a student at the University of Orléans,false,false,true,true,true,true,false
critere_0109,Beck Scale for Suicide Ideation (BSS) score ≥8,unknown,unknown,true,unknown,unknown,true,unknown
critere_0110,Being female,false,false,true,true,true,true,false
critere_0111,"Being pregnant or breastfeeding,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0112,"Being processed Cancer (chemotherapy, radiotherapy or hormone therapy)",unknown,false,unknown,unknown,unknown,true,false
critere_0113,Being under guardianship or curatorship.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0114,Biliary cirrhosis,unknown,false,unknown,unknown,unknown,unknown,false
critere_0115,Blood eosinophilia greater than 4.5 G/I,unknown,false,unknown,unknown,unknown,unknown,false
critere_0116,BMI and Brunt Fibriosis score:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0117,"BMI: 18,5 Kg/m2 ≤ BMI ˂30Kg/m2.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0118,"Body mass index (BMI) between 18.5 and 24.9 kg/m²,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0119,Body Mass Index (BMI) between 35 and 60 kg/m2 inclusive,unknown,false,unknown,unknown,unknown,unknown,false
critere_0120,Body Mass Index (BMI) of 18.0 to 32.0 kg/m2 (inclusive); and a total body weight \>50.0 kg (110 lbs) and \<100.0 kg (220 lbs) at screening and Day -1.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0121,Body mass index \> 35 and \< 50 kg/m2,unknown,false,unknown,unknown,unknown,unknown,false
critere_0122,"bolts, screws",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0123,Brain metastases are allowed only if the following 4 parameters hold:,unknown,false,unknown,unknown,unknown,unknown,false
critere_0124,"C. 1-3 involved axillary lymph nodes and at least one of the following; i) Tumour size \> 3 cm, ii) histological grade 3 iii) high genomic risk defined as Oncotype Dx Recurrence Score \>=26, Prosigna score \>=60, EPclin risk score \>=4.0, or Mammaprint high risk category, or",true,unknown,unknown,unknown,unknown,unknown,unknown
critere_0125,Cancer diagnosed within the last 5 years,unknown,false,unknown,unknown,unknown,false,false
critere_0126,Candidate for Gastric By-Pass,unknown,false,unknown,unknown,unknown,unknown,false
critere_0127,"Candidates for RY gastric By-pass bariatric surgery,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0128,Cardiac arrhythmia.,unknown,false,unknown,true,true,unknown,false
critere_0129,"Cardiac or vascular disease, or a heart condition (including symptoms of Raynaud's syndrome)",true,false,true,true,unknown,unknown,false
critere_0130,CARLSSON score (score ≥ 4) preoperatively,unknown,false,false,false,false,false,false
critere_0131,"Central laboratory serum potassium must meet the following criteria at the Screening Visit, based on screening eGFR:",false,false,false,false,false,false,false
critere_0132,Central nervous system disease stable for \>3 months prior to registration as documented by magnetic resonance imagining (MRI).,false,false,true,false,unknown,unknown,false
critere_0133,"Cerebral vascular lesions (arteriovenous malformation, arteriovenous fistula, aneurysms, significant stenosis of extra- or intra-cranial vessels other than the targeted venous sinus stenosis, intracranial artery dissection, etc.).",true,true,unknown,unknown,true,unknown,true
critere_0134,Certain infectious endocarditis according to Dukes Criteria,unknown,false,true,unknown,unknown,unknown,false
critere_0135,Certificate of no contraindication by a psychiatrist,unknown,false,unknown,true,unknown,unknown,unknown
critere_0136,Certificate of non-contraindication issued by the referring physician,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0137,"CGI-Severity score\<6 assessed by the psychiatrist (Berk et al., 2008) ISMI score indicating moderate to high self-stigma (\>2.5; Lysaker et al., 2007)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0138,Characterized depressive disorder with psychotic characteristics within 3 months before the inclusion (DSM-5),unknown,false,unknown,unknown,unknown,unknown,false
critere_0139,Child-Pugh A or B,unknown,false,unknown,unknown,unknown,unknown,false
critere_0140,Childbearing women must have an efficient contraception for the whole study period,unknown,false,unknown,unknown,unknown,unknown,false
critere_0141,Cholangiocarcinoma,unknown,false,unknown,unknown,unknown,unknown,false
critere_0142,Chronic alcohol or drug abuse,unknown,false,unknown,unknown,unknown,unknown,false
critere_0143,"Chronic hypertension, whether treated or not, know before pregnancy or diagnosed before randomization",true,true,unknown,unknown,unknown,unknown,true
critere_0144,Chronic pain,unknown,false,unknown,unknown,unknown,true,false
critere_0145,Chronic phase (\> 3 months),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0146,Cirrhosis Child B-C,unknown,false,unknown,unknown,unknown,unknown,false
critere_0147,claustrophobia,unknown,false,unknown,unknown,unknown,unknown,false
critere_0148,"Clinical diagnosis of OS, with confirmed TRPV3 or PERP mutation, and visible palmoplantar keratoderma.",true,false,true,true,true,unknown,false
critere_0149,Clinical signs of dysphagia,true,false,true,true,true,true,false
critere_0150,Clinical signs of hypovolemia,true,unknown,true,true,true,true,unknown
critere_0151,Coagulopathy or other pathology that contraindicates biopsy procedures,unknown,false,unknown,unknown,unknown,true,false
critere_0152,"Cognitive deficit (clinical screening, confirmed by an QI \< 80 on the Weschler scale (WISC V), carried out as part of the usual treatment in the event of clinical evidence.",true,unknown,unknown,true,true,true,unknown
critere_0153,"Cognitive impairment pre-existing stroke (CQI code \> 3.4) (Law et al., 1995)",true,unknown,unknown,unknown,true,true,unknown
critere_0154,Collection of informed written consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0155,Collection of informed written consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0156,Complete COVID-19 vaccination schedule according to current guidelines,unknown,unknown,true,unknown,unknown,true,unknown
critere_0157,"Complete portal vein thrombosis (main portal trunk, or right branch), or portal cavernoma",unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0158,Completed adjuvant radiation therapy (if indicated) and recovered before randomization,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0159,"Concomitant participation to another interventional clinical trial, excepted eventual ancillary researches validated by the study scientific committee. Participation to non-interventional researches is allowed.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0160,Consent form signed,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0161,Consumption of at least 1 serving/day of dairy products made from cow's milk,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0162,"Contra-indication to aspirin (bleeding disorders such as von Willebrand's disease, active peptic ulceration, hypersensitivity to aspirin, active peptic ulceration, NSAID-exacerbated respiratory disease, severe liver or heart dysfunction)",unknown,unknown,true,true,unknown,unknown,unknown
critere_0163,"Contra-indication to aspirin, clopidogrel or other P2Y12 anti-aggregant",unknown,false,unknown,true,unknown,unknown,false
critere_0164,Contra-indication to general anesthesia,unknown,false,unknown,true,true,unknown,false
critere_0165,"Contra-indication to MRI : claustrophobia, ocular metallic foreign bodies (accidental or other) or in a risk area (nervous or vascular system);irremovable implanted medical device (pacemaker, neurostimulator, cochlear implants and others);metallic heart valve (mainly old heart valves) or vascular clips previously implanted on cranial aneurysms; gadolinium allergy",unknown,unknown,true,true,true,unknown,unknown
critere_0166,Contraindication to bariatric surgery,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0167,Contraindication to diuretics involved in the algorithm,unknown,false,unknown,true,true,unknown,false
critere_0168,Contraindication to hormonal treatment (see paragraph 1.5),unknown,false,unknown,true,unknown,unknown,false
critere_0169,Contraindication to undergoing brain MRI,unknown,unknown,true,true,unknown,true,unknown
critere_0170,Contraindications or known hypersensitivity to the trial medication or excipients.,true,false,unknown,unknown,unknown,true,false
critere_0171,Contraindications related to the radiofrequency technique:,unknown,false,true,unknown,unknown,true,false
critere_0172,Contraindications to physical activity,unknown,false,unknown,unknown,unknown,true,false
critere_0173,"Covered by a health insurance system where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0174,Criteria relating to contraindications to the explorations provided for by the MRI protocol:,unknown,false,true,true,true,true,false
critere_0175,Criterion A: current characterized depressive disorder and characterized depressive disorder for at least 12 months during the last 24 months despite at least four treatments lines at appropriate dosage and duration,unknown,false,unknown,true,true,true,false
critere_0176,Criterion B: current treatment by ECT and criteria A before the start of the ECT treatment or ECT dependency criteria,unknown,false,unknown,unknown,unknown,unknown,false
critere_0177,Current anticoagulant treatment,unknown,false,unknown,unknown,unknown,unknown,false
critere_0178,Current medical history of cancer requiring chemotherapy,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0179,"Current or recent treatment (within the last 12 months) with other physical methods: vaginal laser, photobiomodulation, PRP injection, hyaluronic acid injection or lipo-modeling.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0180,Current participation in any clinical research trial involving an investigational drug or device within the last 30 days.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0181,Current treatment with medications that are well known to prolong the QT interval.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0182,"Currently participating or participated in any other clinical trial of an IMP or device, within the past 4 months before the screening visit.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0183,"Cutaneous infection of the area to be treated with IMP within 2 weeks before the screening visit or any infection of treatment area requiring treatment with oral, parenteral antibiotics, antivirals, antiparasitics or antifungals or any topical within 2 weeks before the screening visit.",unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0184,Cutaneous infection or another underlying condition of the skin which may impact the assessments or trial participants.,true,unknown,true,true,true,true,true
critere_0185,D. At least one lymph node positive (micrometastasis or macrometastasis) after chemotherapy,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0186,"Decompensated cirrhosis (MELD\> 7 CPT score\> 5, previous history of decompensation (encephalopathy, ascites, jaundice, varicose vein rupture)",true,unknown,unknown,true,true,unknown,unknown
critere_0187,Deficit still existing (Rankin score ≥ 3 and ≤ 4 at inclusion),unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0188,"Definitively treated (e.g., radiotherapy, surgery),",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0189,Dependence on alcohol or psychoactive substances such as drugs,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0190,"Deprived of their liberty by court or administrative decision,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0191,Diabetes,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0192,Diabetes mellitus:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0193,Diabetic foot ulcers.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0194,Diagnosed as having a progressive general pathology,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0195,Diagnosis of Chronic Obstructive Pulmonary Disease (COPD),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0196,"Diagnosis of cirrhosis based on a liver biopsy, or on clinical, biological, endoscopic, and radiological evidence",true,unknown,true,true,true,true,unknown
critere_0197,Diagnosis of Major Depressive Disorder according to the 5th edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria and confirmation by the MINI Structured Clinical Interview,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0198,Diagnosis of recurrent depressive trouble or persistent depressive disorder or bipolar disorder (according to DSM-5),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0199,Dietary restriction (vegetarian or lactovegetarian) or high protein diet,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0200,"Disability, according to the investigator, to understand the study or refusal to sign the study consent form (non-francophone patient, cognitive disorders)",true,false,unknown,true,true,true,false
critere_0201,Distant metastasis at the time of diagnosis;,unknown,false,unknown,unknown,unknown,false,false
critere_0202,"Documented estrogen receptor (ER)-positive tumor in accordance to ASCO/CAP guidelines (Allison et al. 2020),47 assessed locally and defined as ≥1% of tumor cells stained positive.",unknown,false,false,true,true,false,false
critere_0203,"Documented Human epidermal growth factor receptor 2 overexpressing and/or amplified (HER2+), metastatic breast cancer (mBC) or metastatic gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, or esophageal adenocarcinoma (mGEAC).",unknown,false,unknown,unknown,unknown,true,false
critere_0204,"Documented human epidermal growth factor receptor-2 (HER2)-negative tumor in accordance to 2018 ASCO/CAP guidelines (Wolff et al. 2018)48, as determined per local assessment.",true,false,true,true,true,false,false
critere_0205,Documented investigator assessed progression after HER2-directed treatment (including treatment with trastuzumab deruxtecan (T-DXd) for non-T-DXd combination cohorts) for unresectable locally advanced or metastatic disease.,true,false,unknown,unknown,unknown,true,true
critere_0206,Dosed in another clinical trial within at least 10 tissue half-lives prior to dosing or 4 months.,unknown,false,unknown,unknown,false,false,false
critere_0207,Drinking more than 3 glasses of alcohol per day (\>30g/day),unknown,false,unknown,unknown,unknown,unknown,false
critere_0208,Drug abuse within the past year.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0209,"Duodenal ulcer,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0210,"Dyskalemia (\<3,5 mmol/L or \>5,5 mmol/L)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0211,E. Lymph node negative and tumour size \> 3 cm after chemotherapy,unknown,false,unknown,unknown,unknown,false,false
critere_0212,early limitation of life-sustaining care,unknown,unknown,true,true,unknown,true,unknown
critere_0213,Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1,unknown,false,unknown,unknown,true,false,false
critere_0214,Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.,unknown,false,unknown,unknown,true,false,false
critere_0215,Eastern Cooperative Oncology Group (ECOG) score of 0 or 1. Further,unknown,false,false,false,true,false,false
critere_0216,Eastern Cooperative Oncology Group Performance Status 0-1.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0217,Eating disorder or mental disorder,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0218,"ECOG performance status 0, 1 or 2 (see https://ecog-acrin.org/resources/ecog-performance-status)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0219,Effective contraception for women,unknown,false,unknown,unknown,unknown,unknown,false
critere_0220,"Eligible for upfront breast conservative surgery or upfront mastectomy: stage I, stage II or operable stage III (excludes T4) (AJCC Cancer Staging Manual 8th edition 2017).46 Tumor size must be ≥1.0 cm Multicentric and multifocal tumors and bilateral breast cancers are allowed but investigators must ensure the same tumor foci is biopsied pre-treatment and post-treatment (e.g., via clipping of the biopsied tumor foci).",unknown,true,true,unknown,unknown,true,true
critere_0221,Epilepsy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0222,Esophagitis of grade B and above on the Oeso-Gastro-Duodenal Fibroscopy,unknown,false,unknown,unknown,unknown,true,false
critere_0223,Estradiol (E2) in the premenopausal range (according to institution parameters) or Patient has been menstruating regularly during the 6 months prior to screening and has not used any form of hormonal contraception or any other hormonal treatments during this time.,unknown,false,unknown,true,true,unknown,false
critere_0224,"Evidence of an informed consent document, signed and dated by the subject, indicating that the subject has been informed of all pertinent aspects of the study prior to initiation of any subject-mandated procedures.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0225,Evidence of an uncontrolled seizure disorder,unknown,false,unknown,unknown,unknown,unknown,false
critere_0226,"Evidence of intracranial hemorrhage (subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), etc.)",true,unknown,unknown,unknown,true,unknown,unknown
critere_0227,"Evidence or history of clinically relevant hepatic, hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.",true,false,true,true,true,true,false
critere_0228,Except for chemotherapy as neoadjuvant therapy for early-stage TNBC: Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization,unknown,false,unknown,unknown,unknown,false,false
critere_0229,"Except for pembrolizumab as neoadjuvant therapy for early-stage TNBC: received prior therapy with an anti-programmed cell death 1 protein (anti-PD-1), anti-programmed cell death ligand 1 (anti-PD-L1), or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor (eg, cytotoxic T-lymphocyte-associated protein-4 \[CTLA-4\], OX-40 \[cluster of differentiation (CD) 134\], or CD137)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0230,Existing declaration of informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0231,Expected follow-up \< 3 months,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0232,"Exposure to an oral drug (other than ACZ), substance, or disorder that has been associated with elevation of intracranial pressure within 2 months of diagnosis (lithium, vitamin A, tetracycline and related compounds)",false,true,true,true,true,true,true
critere_0233,Extra-hepatic cancer without remission,unknown,false,unknown,unknown,unknown,true,false
critere_0234,"Failure of other medical cares (medical, nutritional, dietetic and psychotherapeutic treatment) well conducted for 6 to 12 months.",false,false,true,true,false,true,false
critere_0235,"Female and male patients of reproductive potential must be willing to use an adequate method of contraception for the first three years of the trial, if randomised to standard endocrine therapy for the duration of trial treatment through to at least 4 weeks after the last dose of trial treatment, and if randomised to fulvestrant and palbociclib to 2 years after the last dose of fulvestrant (see section 4.6). Note: Abstinence is acceptable if this is the usual lifestyle and preferred contraception for the patient.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0236,"Female participants of non-childbearing potential, childbearing potential and males capable of fathering a child must meet the contraception requirements.",unknown,false,unknown,unknown,unknown,true,false
critere_0237,"Female participating in the study must be either of non-child bearing (surgically sterilized at 6 month prior to screening or postmenopausal) or using an efficient contraception: hormonal contraception (including patch, contraceptive ring etc) intra-uterine device or other mechanical contraception",unknown,false,unknown,unknown,unknown,true,false
critere_0238,Fibroscan ≥ 9kPa or FibrometreVM ≥0.526 predicting a F3 or F4 fibrosis score grade within 1 month before inclusion Or F3 or F4 fibrosis score grade diagnosed by hepatic biopsy performed before inclusion.,unknown,false,unknown,unknown,unknown,false,false
critere_0239,First cerebral infarction,true,false,unknown,unknown,unknown,unknown,false
critere_0240,"First stroke ever \< 6 weeks, confirmed by imaging,",true,false,true,true,true,true,false
critere_0241,flutter patient or atrial fibrillation,unknown,false,unknown,unknown,unknown,unknown,false
critere_0242,Food allergies or intolerance to dairy products,unknown,false,unknown,unknown,unknown,unknown,false
critere_0243,"For a woman of childbearing potential, plan to be non-pregnant AND use of highly effective contraception from screening until the end of the trial.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0244,For all experiments:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0245,For All Experiments:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0246,For all subjects:,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0247,"For child-bearing aged women, contraception using oestroprogestative, progestative, intrauterine device, or mechanical contraception",unknown,false,unknown,unknown,unknown,unknown,false
critere_0248,for ctDNA Surveillance:,unknown,false,unknown,unknown,unknown,true,false
critere_0249,"For dose optimization (Phase II): Patient must provide tumor tissue from locations not radiated prior to biopsy, if possible, collected through archival tissue.",unknown,false,false,false,false,false,false
critere_0250,For F3 fibrosis patients: 35\>BMI≥ 30kg/m² ; Fibroscan ≥ 9kPa or FibrometreVM ≥0.526 predicting a F3 fibrosis score grade within 1 month before inclusion or F3 fibrosis score grade diagnosed by hepatic biopsy performed before inclusion.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0251,For F4 fibrosis patients: 50\>BMI≥ 30kg/m² ; Fibroscan ≥ 15kPa predicting a F4 fibrosis score grade within 1 month before inclusion or F4 fibrosis score grade diagnosed by hepatic biopsy performed before inclusion.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0252,"For females (assigned at birth), is not pregnant or breastfeeding and ≥1 of the following applies: is not a participant of childbearing potential (POCBP) OR is a POCBP and uses highly effective contraception after the last dose of study intervention (210 days for sacituzumab tirumotecan, 120 days for pembrolizumab, and 185 days for capecitabine). Abstains from breastfeeding during the study intervention period and for at least 120 days after study intervention",unknown,true,unknown,unknown,unknown,unknown,unknown
critere_0253,"For hypertensive patients, hypertension must be controlled by stable dose of anti-hypertensive medication for at least 2 months prior to screening (and the stable dose can be maintained throughout the study).",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0254,"for participants with screening eGFR \< 45 mL/min/1.73 m2, potassium must be ≥ 3.0 and ≤ 4.5 mmol/L at the Screening Visit",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0255,"for participants with screening eGFR ≥ 45 mL/min/1.73 m2, potassium must be ≥ 3.0 and ≤ 4.8 mmol/L at the Screening Visit",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0256,For patients only : diagnosed with Binge Eating Desordors according to DSM criteria.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0257,"For patients taking part in the RTW WP: patient in an ""self employed"" or ""interim"" employment situation",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0258,For patients taking part in the RTW WP: Patients working part-timeProcedures for withdrawal of incorrectly enrolled patients are presented in Section 7.5.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0259,For patients taking part in the RTW WP: working patients at time of diagnostic and in sick leave at time of inclusion,unknown,unknown,true,true,true,true,unknown
critere_0260,"For patients with cirrhosis, patients must fulfil all the following criteria: Platelets \> 125 000, PT \> 80 %, Albumin \> 35 g/L, MELD score at inclusion \< 9, CPT score \< 6, No history of previous decompensation, No oesophageal varices (endoscopy), No vascular shunt, ASA score ≤ III, Alcohol consumption lower than 20g/day for women and 30g/day for men.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0261,For patients:,unknown,unknown,true,true,true,true,unknown
critere_0262,For relatives :,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0263,For the subjects of the group NO:,unknown,unknown,true,true,true,true,unknown
critere_0264,For women of childbearing age: effective contraception implemented for at least 3 months.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0265,"free patient, without tutorship or curatorship or under judicial protection",unknown,false,unknown,unknown,unknown,unknown,false
critere_0266,"Free, informed and signed consent by the participant and/or the person having guardianship and the investigator (at the latest on the day of inclusion and before any examination required by the research);",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0267,French as native language,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0268,"Fulminant decrease of visual acuity due to the IIH defined as a visual loss (of the most seriously impaired eye) of at least 3/10 (from corrected vision) within 4 weeks, in absence of any other ophthalmologic pathology and Mean Deficit of visual field superior to -10 dB",false,false,unknown,false,false,unknown,unknown
critere_0269,"Gastic Banding, Biliopancreatic diversion and all the new bariatric surgery techniques are forbidden because the study design allow only the laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric Bypaass.",unknown,true,unknown,unknown,true,unknown,true
critere_0270,Gestational age \<11 WG and \>14 WG,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0271,Girls aged 14 to 18 playing handball Handballers training at the Pôle Espoirs or the Centre Labellisé d'Entrainement 29 Players of legal age who have given their consent Signature of consent by parents for underage players,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0272,glasses (given the participant cannot use contact lenses),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0273,Global or sensory aphasia,unknown,false,unknown,unknown,unknown,unknown,false
critere_0274,"Good general health as determined at the discretion of the investigator (vital signs, medical history, and physical examination).",true,false,true,unknown,true,unknown,false
critere_0275,"Gout,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0276,Had adequate excision and surgical removal of all clinically evident disease in the breast and/or lymph nodes and have adequately recovered from surgery,unknown,unknown,true,true,true,true,unknown
critere_0277,Had neoadjuvant treatment based on the KEYNOTE-522 regimen (pembrolizumab with carboplatin/taxanes and pembrolizumab with anthracycline-based chemotherapy) followed by surgery according to National Comprehensive Cancer Network (NCCN) treatment guidelines for TNBC,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0278,Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 28 days prior the first dose of study drugs,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0279,Has a known germline breast cancer gene (BRCA) mutation (deleterious or suspected deleterious) and is eligible for adjuvant therapy with olaparib where olaparib is approved and available,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0280,"Has active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed",unknown,unknown,true,unknown,unknown,true,unknown
critere_0281,Has active infection requiring systemic therapy,unknown,unknown,true,unknown,true,true,unknown
critere_0282,"Has active inflammatory bowel disease requiring immunosuppressive medication or previous history of inflammatory bowel disease (eg, Crohn's disease, ulcerative colitis, or chronic diarrhea)",unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0283,"Has centrally confirmed TNBC, as defined by the most recent American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0284,Has concurrent active hepatitis B and hepatitis C virus infection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0285,Has diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0286,Has expressed interest and availability to meet the trial requirements.,unknown,unknown,true,unknown,true,unknown,true
critere_0287,Has Grade \>2 peripheral neuropathy,unknown,unknown,unknown,unknown,true,true,unknown
critere_0288,Has history of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0289,Has history of allogeneic tissue/solid organ transplant,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0290,Has known additional malignancy that is progressing or has required active treatment within the past 5 years,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0291,"Has no evidence of locoregional or distant relapse, as assessed by the treating physician",true,unknown,unknown,unknown,unknown,true,true
critere_0292,Has non-pathologic complete response at surgery,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0293,Has provided tissue from the surgical resection for central laboratory determination of trophoblast cell surface antigen 2 (TROP2) status,unknown,unknown,true,true,true,true,unknown
critere_0294,Has received an investigational agent or has used an investigational device within 4 weeks prior to study intervention administration,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0295,"Has uncontrolled, significant cardiovascular disease or cerebrovascular disease including New York Heart Association Class III or IV congestive heart failure, unstable angina, myocardial infarction, uncontrolled symptomatic arrhythmia, prolongation of QTcF interval to \>480 ms, and/or other serious cardiovascular and cerebrovascular diseases within 6 months prior to study intervention",unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0296,Have a BMI between 18.5 and 30 kg/m2,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0297,Have a history of (non-infectious) pneumonitis / interstitial lung disease that required steroids or has current pneumonitis / interstitial lung disease,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0298,Have a known additional malignancy that is progressing or has required active treatment within the past 3 years.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0299,Have a known history of Hepatitis B (defined as HBsAg reactive) or known active Hepatitis C virus (defined as HCV RNA \[qualitative\] is detected) infection.n.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0300,Have a known history of HIV infection,unknown,false,unknown,unknown,unknown,unknown,false
critere_0301,"Have achieved a minimal BMI \< 18.5 or maximal BMI ≥ 25 kg/m² in adult life,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0302,"Have adequate hematological, hepatic and renal functions.",unknown,false,true,unknown,unknown,true,false
critere_0303,"Have an active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs).",unknown,false,true,unknown,false,true,false
critere_0304,Have an active infection requiring systemic therapy,unknown,false,true,unknown,true,true,false
critere_0305,"Have any other condition or reason that, in the opinion of the Investigator, would prohibit the subject from participating in the study.",true,false,true,true,true,true,true
critere_0306,"Have at least 1 injectable measurable cutaneous, subcutaneous or nodal lesion (direct injection or through the use of ultrasound guidance) not exceeding 50mm in longest diameter and whenever possible 1 distant non-injected measurable lesion.",true,false,unknown,false,true,false,false
critere_0307,Have failed and/or are intolerant to standard therapeutic options.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0308,Have had an allogenic tissue/solid organ transplant or allogenic stem cell or bone marrow transplantation,unknown,false,unknown,unknown,unknown,unknown,false
critere_0309,"Have had an ischemic and/or hemorrhagic stroke (\> 3 months post-stroke), impacting the motor skills of the upper limbs,",false,false,unknown,false,true,true,false
critere_0310,Have had major surgery within 4 weeks of first study drug administration.,unknown,false,false,false,false,false,false
critere_0311,"Have histologically confirmed, advanced/metastatic sarcoma (soft tissue and bone), Merkel cell carcinoma, melanoma, triple negative breast cancer or non-small cell lung cancer, with cutaneous or, palpable subcutaneous lesions or easily injectable lymph nodes.",unknown,false,unknown,unknown,true,true,false
critere_0312,Have Internet access at home (computer) and are able to use the digital platform.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0313,Have known active CNS metastases and/or carcinomatous meningitis.,unknown,false,unknown,unknown,unknown,true,false
critere_0314,Have no contraindication to the practice of physical activity,unknown,false,unknown,true,unknown,unknown,false
critere_0315,Have received or receiving any live or live-attenuated vaccine within 30 days prior to the first dose of study intervention..,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0316,Have received prior radiotherapy within 2 weeks of start of study treatment or have had a history of radiation pneumonitis,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0317,Have received prior systemic anti-cancer therapy including investigational agents within 4 weeks prior to the start of treatment.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0318,"Have received prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor (e.g., CTLA-4, OX 40, CD137), and was discontinued from that treatment due to a Grade 3 or higher immune-related Adverse Event (irAE).",unknown,false,false,false,true,false,false
critere_0319,Have received prior treatment with a vaccinia oncolytic virus.,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0320,"Have severe hypersensitivity to the active substance or, to any of the excipients of (≥Grade 3) to pembrolizumab. and/or any of its excipients",unknown,false,false,unknown,unknown,true,false
critere_0321,Having dated and signed an informed consent.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0322,Having given oral consent.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0323,Having given written consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0324,Having initiated puberty: tanner score ≥2 for FtM; tanner score ≥2 (clinic and/or testosterone \>0.3 ng/mL) for MtF,unknown,false,unknown,unknown,unknown,true,false
critere_0325,Having received any of the prohibited treatments in Table 2 within the specified timeframe before inclusion.,unknown,false,false,unknown,unknown,false,false
critere_0326,Having signed the consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0327,Having signed the consent form,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0328,Having treatment for a pathology at the time of inclusion,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0329,Healthy female and male participants.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0330,heart failure requiring inotropic administration at the time of randomization,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0331,"Hemiparesis or hemiplegia of the upper limb (FMA-UE score \< 48), particularly in the wrist and elbow flexors,",true,unknown,unknown,unknown,unknown,unknown,unknown
critere_0332,"Hemostasis disorders, including hemophilia (with thrombocytopenia)",unknown,unknown,true,unknown,unknown,true,unknown
critere_0333,"Hepatitis C, HIV infection (assay performed within 6 months prior to diagnosis of pre- eclampsia)",unknown,false,false,unknown,false,false,false
critere_0334,Hepatocellular carcinoma,unknown,false,unknown,unknown,unknown,unknown,false
critere_0335,"Hepatocellular carcinoma with at least one nodule \> 3 cm in diameter, or more than 3 nodules",true,false,unknown,unknown,true,true,true
critere_0336,High blood pressure or poor circulation,true,false,unknown,true,true,unknown,false
critere_0337,"High likelihood of HVPG ≥ 12 mm Hg based on investigator's judgement, or on the following criteria:",unknown,false,unknown,unknown,unknown,unknown,false
critere_0338,Histological or cytological confirmation of ER+/HER2 - disease,unknown,false,unknown,unknown,unknown,true,false
critere_0339,"Histologically confirmed, operable invasive breast carcinoma.",unknown,false,unknown,unknown,unknown,true,false
critere_0340,"Histologically proven primary ER+ (Allred score 6/8 or greater, or stain in ≥10% of cancer cells) and HER2- (immunohistochemistry 0/1+ and/or negative by in situ hybridization) breast cancer as determined by local laboratory",unknown,false,unknown,unknown,unknown,false,false
critere_0341,"History of a pulmonary embolus (PE), deep vein thrombosis (DVT), or any known thrombophilia, unless the event occurred greater than 6 months prior to screening and the subject is treated with chronic anticoagulant therapy such as apixaban (Eliquis) or rivaroxaban (Xarelto).",true,false,unknown,unknown,true,true,false
critere_0342,"History of allergic reactions to dust and/or horsehair, or severe asthma",unknown,false,unknown,unknown,unknown,unknown,false
critere_0343,"History of angina pectoris, symptomatic pericarditis, myocardial infarction, or any cardiac arrhythmias (e.g., ventricular, supraventricular, nodal arrhythmias, or conduction abnormality) within 12 months prior to study entry History of documented congestive heart failure (New York Heart Association Class II-IV) or cardiomyopathy Left ventricular ejection fraction \<50% as determined by multiple-gated acquisition scan or echocardiogram QT interval corrected through use of Fridericia's formula (QTcF) \>470 ms based on mean value of triplicate ECGs, history of long or short QT syndrome, Brugada syndrome or known history of corrected QT interval prolongation, or torsades de pointes History or presence of an abnormal ECG that is clinically significant in the investigator's opinion, including complete left bundle branch block, second- or third-degree heart block, sick sinus syndrome, or evidence of prior myocardial infarction",unknown,false,true,true,false,true,false
critere_0344,History of atrial fibrillation or other risks of stroke,true,false,unknown,unknown,unknown,unknown,false
critere_0345,History of bariatric or digestive surgery or disease interfering with main outcomes,true,false,true,unknown,unknown,unknown,false
critere_0346,"History of cancer, except:",unknown,false,unknown,unknown,unknown,true,false
critere_0347,History of chronic obstructive pulmonary disease or other severe respiratory disease,unknown,false,unknown,true,true,unknown,false
critere_0348,"History of chronic rhinitis, nasal septal defect, cleft palate, nasal polyps, or other nasal abnormality that might alter nasal mucosa and affect vaccine response.",unknown,false,unknown,true,true,unknown,false
critere_0349,History of clinical ascites,unknown,false,unknown,unknown,unknown,unknown,false
critere_0350,history of clinical ascites in the last 6 months,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0351,History of deep vein thrombosis or pulmonary embolism,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0352,"History of documented hemorrhagic diathesis, coagulopathy, or thromboembolism.",true,unknown,true,unknown,true,true,unknown
critere_0353,"History of documented severe dry eye syndrome, severe Meibomian gland disease and/or blepharitis, or severe corneal disease that prevents/delays corneal healing",unknown,true,unknown,true,true,unknown,true
critere_0354,History of fainting or seizures,unknown,unknown,unknown,true,true,unknown,unknown
critere_0355,History of frequent epistaxis.,unknown,false,unknown,unknown,true,true,false
critere_0356,History of frostbite,unknown,false,unknown,unknown,unknown,unknown,false
critere_0357,History of Grade 3 or Grade 4 interstitial lung disease (ILD) on previous therapy.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0358,History of horse riding or hippotherapy care during the last 6 months,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0359,History of intracranial venous thrombosis or intracranial neoplasia,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0360,"History of lactic acidosis, diabetic acidocetosis, or diabetic precoma",unknown,false,unknown,true,true,unknown,false
critere_0361,History of long QTc (Q-T interval corrected for heart rate) syndrome or a QTc of \>480 msec.,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0362,"History of malignancy within the past 5 years (excluding breast cancer), except basal cell or squamous cell carcinoma of the skin curatively treated by surgery.",unknown,true,unknown,unknown,unknown,true,true
critere_0363,"History of myocarditis or congestive heart failure, unstable angina, uncontrolled infection, or myocardial infarction 6 months prior to clinical trial entry.",unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0364,History of non-compliance to medical regimens.,unknown,unknown,true,unknown,true,true,unknown
critere_0365,"History of organ transplant or bone marrow transplant, or planned organ transplant within 6 months following randomisation (including kidney transplant).",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0366,History of PE in a previous pregnancy,unknown,unknown,unknown,unknown,true,true,unknown
critere_0367,History of previously implanted intra-cranial sinus stent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0368,History of regular alcohol consumption exceeding 14 drinks/week for females or 21 drinks/week for males within 6 months of screening.,unknown,unknown,unknown,unknown,unknown,unknown,true
critere_0369,"History of severe adverse events following vaccine administration including anaphylactic reaction and associated symptoms such as rash, breathing problems, angioedema, and abdominal pain, or a history of allergic reaction that could be triggered by a component of the SARS-COV-2 vaccine at the time of the first vaccine administration.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0370,"History of severe exfoliative skin conditions (e.g., eczema or atopic dermatitis) requiring systemic therapy for more than 4 weeks within 2 years prior to BT-001 initiation.",unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0371,"History of severe PE with delivery \< 34 weeks of gestation,",unknown,false,true,true,true,true,false
critere_0372,History of severe psychiatric disorders that may affect participation in the trial.,unknown,false,unknown,true,true,unknown,false
critere_0373,History of TIPS (transjugular intrahepatic portosystemic shunt) / surgical portosystemic derivation / liver transplantation / major hepatectomy,unknown,false,unknown,unknown,true,unknown,false
critere_0374,History of uncontrolled pain,true,unknown,true,true,true,true,true
critere_0375,History of upper limb surgery less than 6 months old.,unknown,unknown,unknown,true,true,unknown,unknown
critere_0376,"History of ventricular dysrhythmias or risk factors for ventricular dysrhythmias such as structural heart disease (e.g., severe left ventricular systolic dysfunction, left ventricular hypertrophy), coronary heart disease (symptomatic or with ischemia demonstrated by diagnostic testing), clinically significant electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia, hypocalcemia), or family history of long QT syndrome.",true,unknown,true,true,true,true,unknown
critere_0377,"History or ongoing allergy/hypersensitivity, as judged by the investigator, to SGLT2 inhibitor (eg, empagliflozin) or ASI.",unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0378,"History or presence of symptomatic bradycardia or resting heart rate \<50 bpm at screening. Patients on stable dose of a beta-blocker or calcium channel antagonist for pre-existing baseline conditions (e.g., hypertension) may be permitted if resting heart rate is ≥50 bpm.",unknown,false,unknown,unknown,true,unknown,false
critere_0379,HIV positive patients,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0380,HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0381,Hormonal treatment needs to be adjusted (FtM patients treated with anti-coagulants or with thrombophilia).,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0382,Hospital admission due to neurovascular emergency,true,unknown,unknown,true,true,unknown,unknown
critere_0383,"Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0384,Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0385,"Human immunodeficiency virus, or hepatitis B virus, or hepatitis C virus positive serum,",unknown,unknown,true,unknown,unknown,true,unknown
critere_0386,"Hypersensitivity to salicylates such as aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs),",unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0387,Hyponatremia (\<130 mmol/L),unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0388,hypotension and / or severe hypovolemia with hemodynamic instability,unknown,unknown,unknown,true,true,unknown,unknown
critere_0389,ICHT at the time of randomisation (ICP\> 25 mmHg for at least 20 min),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0390,"If anticoagulation therapy is required for a prosthetic heart valve, stable INR between 2.5 and 3.5 is permitted.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0391,"If capable of producing sperm, the participant agrees to the following during the intervention period and for at least the time needed to eliminate each study intervention after the last dose of study intervention (120 days for sacituzumab tirumotecan and 95 days for capecitabine \[no restriction for pembrolizumab\]): agrees to refrain from donating sperm AND is either abstinent and agrees to remain abstinent or uses highly effective contraception",unknown,true,unknown,unknown,unknown,unknown,true
critere_0392,Illicit drug use within the past 12 months.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0393,Impossibility of giving the person informed information and ensuring the subject's compliance due to impaired physical and/or psychological health,true,unknown,true,true,true,true,true
critere_0394,"Impossibility to submit to the medical follow-up of this clinical trial for geographical, social or psychological reasons",true,unknown,true,true,true,true,true
critere_0395,In a palliative situation where life expectancy is \< 3 months,true,unknown,unknown,true,true,true,unknown
critere_0396,Inability for the parents (or legal representative) to understand/fulfil study requirements;,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0397,Inability or medical contraindication to travel to the Equiphoria Institute by personal car or taxi,unknown,unknown,true,true,unknown,unknown,unknown
critere_0398,Inability to understand French,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0399,Inability to understand rehabilitation instructions and/or actively participate in the rehabilitation process,true,unknown,unknown,true,unknown,unknown,unknown
critere_0400,"Incident cases, or prevalent cases with stable disease over the last 3 months",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0401,"Incident cases, or prevalent cases with stable disease over the last 3 months",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0402,"Including patients under guardianship, curatorship,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0403,"Including relative under guardianship, curatorship",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0404,Inclusion \> 3 months post-stroke,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0405,Indication of any systemic therapeutic strategy can be performed alongside this current cohort in accordance with national and / or international recommendations.,true,false,true,true,true,true,true
critere_0406,Individual deprived of liberty or placed under the authority of a tutor,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0407,Individual has a baseline office diastolic blood pressure ≥ 90 mmHg,unknown,false,unknown,unknown,unknown,unknown,false
critere_0408,Individual has a documented condition that would prohibit or interfere with ability to obtain an accurate blood pressure measurement,unknown,false,unknown,unknown,unknown,unknown,false
critere_0409,Individual has an average systolic baseline home blood pressure ≥135 mmHg,unknown,false,unknown,false,unknown,unknown,false
critere_0410,Individual has an estimated glomerular filtration rate (eGFR) of \<45,unknown,false,unknown,unknown,unknown,false,false
critere_0411,Individual has documented type 1 diabetes mellitus or poorly-controlled type 2 diabetes mellitus with glycosylated hemoglobin greater than 8.0%,unknown,false,unknown,unknown,unknown,true,false
critere_0412,Individual has one or more episode(s) of orthostatic hypotension,true,false,false,false,true,false,false
critere_0413,Individual has primary pulmonary hypertension,unknown,false,unknown,unknown,unknown,unknown,false
critere_0414,Individual has undergone prior renal denervation,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0415,Individual is diagnosed with hypertension and has a baseline office systolic blood pressure ≥140 mmHg,true,unknown,unknown,unknown,unknown,unknown,unknown
critere_0416,"Individual is pregnant, nursing or planning to become pregnant",unknown,false,unknown,true,true,unknown,true
critere_0417,Individual lacks appropriate renal artery anatomy,false,false,unknown,unknown,unknown,unknown,false
critere_0418,Individual requires chronic oxygen support or mechanical ventilation other than nocturnal respiratory support for sleep apnea,true,false,unknown,unknown,true,unknown,false
critere_0419,Individual with history of osteoporotic fracture and / or pathology or treatment causing secondary osteoporosis,true,unknown,unknown,true,true,true,unknown
critere_0420,"Individual with severe spasticity of adductor muscles, hamstring, quadriceps and triceps surae. Severe spasticity is defined by a score of 4 on the modified Ashworth scale",true,unknown,unknown,unknown,unknown,unknown,unknown
critere_0421,Individually deprived of liberty or placed under the authority of a tutor,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0422,Inflammatory breast cancer (cT4d).,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0423,Informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0424,Informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0425,Initial BMI \<35Kg/m².,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0426,Initial BMI between 35Kg/m² and 40 Kg/m² associated with at least one severe comorbidity likely to be improved after surgery according to HAS recommendations.,unknown,false,true,true,true,true,false
critere_0427,Initial BMI between 35Kg/m² and 40 Kg/m² without comorbidities.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0428,Inpatient or outpatient at the Adult Psychiatry Service,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0429,"INR \<1.5× ULN and PTT \<1.5x ULN Except for patients receiving anticoagulation therapy. For patients receiving warfarin, a stable INR between 2 and 3 is required. For patients receiving heparin, PTT between 1.5 and 2.5 x ULN (or value before patient started heparin treatment) is required.",unknown,true,true,unknown,unknown,true,true
critere_0430,Insufficient knowledge of French,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0431,Interstitial lung disease that is symptomatic and may interfere with the detection or management of suspected drug-related pulmonary toxicity,unknown,false,true,true,true,true,false
critere_0432,Investigator's judgement,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0433,Is able to continue on adjuvant pembrolizumab,unknown,false,unknown,unknown,unknown,unknown,false
critere_0434,Is currently participating in or has participated in a study of an investigational agent or has used an investigational device within 4 weeks prior to the first dose of study treatment,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0435,Is currently receiving a strong inducer/inhibitor of cytochrome P450 3A4 (CYP3A4) that cannot be discontinued for the duration of the study. The required washout period before starting sacituzumab tirumotecan is 2 weeks,unknown,false,unknown,unknown,unknown,unknown,false
critere_0436,Is taking an anticoagulant medication that cannot be interrupted prior to IT injections,unknown,false,unknown,unknown,unknown,unknown,false
critere_0437,Ischemic or haemorrhagic stroke according to ICD 10 I61-I69 (30),true,false,unknown,unknown,unknown,unknown,false
critere_0438,"It is impossible to correctly inform the patient (language barrier, etc.)",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0439,"It is impossible to correctly inform the patient (language barrier, etc.)",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0440,IUD intrauterine device,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0441,"Judgement by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirements.",unknown,false,unknown,unknown,true,unknown,false
critere_0442,Ki 67 ≥10% in diagnostic biopsy as determined per local assessment.,true,false,true,true,true,true,false
critere_0443,Know pregnancy or breastfeeding,unknown,false,unknown,unknown,unknown,unknown,false
critere_0444,Known allergic reaction to plastic.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0445,Known allergy to milk proteins,unknown,false,unknown,unknown,unknown,unknown,false
critere_0446,"Known clinically significant history of liver disease consistent with Child-Pugh Class B or C, including hepatitis.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0447,"Known contrast product, Nickel, titanium allergy",unknown,false,unknown,unknown,unknown,unknown,false
critere_0448,Known ectopic pregnancy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0449,"Known hyperkalaemia, defined as potassium of ≥ 5.5 mmol/L within 3 months at screening.",unknown,false,unknown,unknown,false,false,false
critere_0450,Known hypersensitivity to all the iodin-containing contrast agents,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0451,Known hypersensitivity to beta-lactam antibiotics if the patient has a history of valve replacement,unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0452,Known hypersensitivity to lidocaine for local anesthesia,unknown,unknown,unknown,true,unknown,true,unknown
critere_0453,known hypersensitivity to milrinone or any of the excipients,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0454,Known hypersensitivity to the active substance or any of the excipients,unknown,unknown,true,unknown,unknown,true,unknown
critere_0455,"Known infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV).",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0456,Known issues with swallowing oral medication.,true,unknown,true,unknown,unknown,unknown,unknown
critere_0457,Known multiple pregnancy,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0458,Known non-ongoing pregnancy,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0459,Known RB1 mutations or deletions that in the opinion of the investigator confer resistance to CDK4/6i. (Screening for RB1 mutation is not required for entry.),unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0460,Known relevant allergy to any drug or excipients in the formulation,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0461,Known relevant allergy to any drug or excipients in the formulation.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0462,Known sensitivity to any of the ingredients of the trial vaccines.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0463,known severe obstructive heart diseases,unknown,unknown,true,true,unknown,unknown,unknown
critere_0464,Lasofoxifene is not recommended for use in subjects with conditions that place them at increased risk for VTEs (such as severe congestive heart failure \[CHF\] or prolonged immobilization).,true,true,true,true,true,true,true
critere_0465,Left-handed,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0466,Legal issues: care under constraint or patient deprived of freedom because of a judicial measure 13. Patient who does not speak and read French sufficiently,unknown,false,false,false,true,true,true
critere_0467,"Life expectancy of less than 1 year related to comorbidities (end stage cancer, end stage organ failure)",unknown,false,unknown,unknown,unknown,true,false
critere_0468,Life expectancy under 6 months,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0469,Locally advanced and/or metastatic ER+ breast cancer with radiological or clinical evidence of progression on an AI in combination with either palbociclib or ribociclib as their first hormonal treatment for metastatic disease.,true,unknown,true,true,true,true,true
critere_0470,Locally advanced or metastatic breast cancer with either measurable (according to RECIST 1.1) or non-measurable lesions.,true,unknown,unknown,true,true,true,unknown
critere_0471,Lymphangitic carcinomatosis involving the lung.,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0472,MADRS score ≥ 18,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0473,"Major adverse cardiovascular event during the last three months: myocardial infarction, heart failure hospitalization, stroke",false,false,true,false,true,true,false
critere_0474,Major cognitive impairment affecting comprehension (Mini Mental State Examination test \< 24 points),true,false,unknown,false,true,true,false
critere_0475,major hydroelectrolytic disorders (hypokalemia \<3 mmol / L),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0476,major patient (≥ 18 years),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0477,Major protected by law,unknown,unknown,true,true,true,true,unknown
critere_0478,Major surgery within 4 weeks prior to randomization.,unknown,false,false,false,false,false,false
critere_0479,Major surgery within the last 3 months or any planned surgery during the trial.,unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0480,"Major surgery within the last 3 months, or minor surgery (requiring local anesthetic) during last 1 month, or any planned surgery during the trial.",unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0481,Male or female \>=18 years and \<80 years of age,unknown,unknown,true,true,true,true,unknown
critere_0482,"Male or female child with a genetically confirmed diagnosis of PWS (patients can be enrolled if the genetic subtype is not available at inclusion, but the genetic subtype needs to be confirmed during the study);",false,false,unknown,false,unknown,unknown,false
critere_0483,Male or female patients ≤18 years old,unknown,unknown,true,true,true,true,unknown
critere_0484,Male or female patients ≥ 18 years of age,unknown,unknown,true,true,true,true,unknown
critere_0485,Male or female patients aged 18 years or older,unknown,unknown,true,true,true,true,unknown
critere_0486,Male subjects: Non-sterilized male subjects who are not abstinent and intend to be sexually active with a female partner of childbearing potential must use a male condom from consent through 90 days after the last dose of IP.,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0487,"Malnourished patient (BMI \<18.5 kg / m2, weight loss greater than 5% in 1 month or 10% in 6 months)",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0488,Man or woman older than 18 years oldRight-handed,unknown,unknown,true,true,true,true,unknown
critere_0489,"Medical history requiring anticoagulation (antiphospholipid syndrome, deep vein thromboembolic disease, pulmonary embolism, atherothrombosis, patient with mechanical heart valves),",true,unknown,unknown,true,true,true,unknown
critere_0490,Medical insurance coverage,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0491,Medical problems due to alcohol.,true,unknown,true,true,true,true,unknown
critere_0492,"Medically stable on medical assessment, with no contraindications to stroke rehabilitation management management (no medical problems or acute intercurrent medical events),",true,true,true,true,true,true,true
critere_0493,Medications interfering with intestinal microbiota (beta-lactamines within 3 months before the study or laxatives),unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0494,Membership of a French social security scheme or beneficiary of such a scheme.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0495,Men and women aged between 18 and 65 years,unknown,unknown,true,true,true,true,unknown
critere_0496,Men and women between 18-70 years,unknown,unknown,true,true,true,true,unknown
critere_0497,Menopausal women,unknown,unknown,true,true,true,true,unknown
critere_0498,Metabolic disease requiring a a low protein diet,unknown,unknown,true,unknown,unknown,unknown,unknown
critere_0499,metallic glitter in the eyes,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0500,Mineralocorticoid receptor antagonists,unknown,false,unknown,unknown,unknown,unknown,false
critere_0501,Minimal abduction of the hip of 25 degrees bilateral with no history of hip dislocation and/or dysplasia,unknown,false,unknown,unknown,unknown,unknown,false
critere_0502,minute walking test on day of inclusion,unknown,false,unknown,unknown,unknown,unknown,false
critere_0503,minute walking test on day of inclusion,unknown,false,unknown,unknown,unknown,unknown,false
critere_0504,Misunderstanding of the protocol,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0505,MRI contraindications,unknown,false,true,true,unknown,unknown,false
critere_0506,"Mucocutaneous disease with vulvovaginal localization: infection, sore, scleratrophic lichen, psoriasis, eczema, etc.",true,false,unknown,true,unknown,unknown,false
critere_0507,Multidisciplinary follow-up of at least 6 months before surgery,true,false,unknown,false,false,false,false
critere_0508,Must not be taking any medication that could potentially impair hepatic or renal function at the time of screening.,unknown,false,false,false,unknown,true,true
critere_0509,Need for at least one paracentesis for ascites fluid evacuation in the last 6 months,unknown,false,unknown,unknown,unknown,unknown,false
critere_0510,Negative serum or urine beta HCG pregnancy test within 5 weeks prior to randomization.,unknown,false,false,unknown,unknown,false,false
critere_0511,"Negative serum pregnancy test at screening, and negative urinary pregnancy test at Day -1.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0512,Neo- or adjuvant chemotherapy followed by radiotherapy;,unknown,false,unknown,unknown,unknown,true,false
critere_0513,Neoadjuvant chemotherapy (chemotherapy prior to surgery),unknown,false,unknown,unknown,unknown,false,false
critere_0514,Neoadjuvant endocrine therapy (endocrine based therapy prior to surgery) Use the primary surgery criteria - staging tumour size and lymph node status may be either the pathological staging after endocrine therapy or on the initial clinical staging prior to neoadjuvant therapy,true,false,false,false,false,false,false
critere_0515,Neurodegenerative disease with perineal involvement,unknown,false,unknown,true,unknown,unknown,false
critere_0516,Neurological or psychiatric co-morbidity (other than mild-to-moderate post-stroke depression),true,false,unknown,unknown,unknown,true,false
critere_0517,"Neurological or psychiatric condition known to affect pain tolerance (e.g., peripheral neuropathy, schizophrenia)",true,unknown,unknown,true,true,true,unknown
critere_0518,Neurological or psychiatric illnesses or a history of such problems that could impact quality/variability of data or cooperation and retention of the subject in the study,true,false,true,true,true,true,true
critere_0519,New York Heart Association (NYHA) severity classes II to IV,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0520,New York Heart Association (NYHA) severity classes II to IV,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0521,New York Heart Association functional HF class IV at screening.,unknown,false,unknown,true,unknown,unknown,false
critere_0522,"Newly diagnosed treatment-naïve cervical cancer patients (1) stage Ia - IIa1 with nodal metastasis, postoperative positive margin or parametrial-vaginal involvement, and (2) stage ≥IIa2).",true,unknown,unknown,unknown,true,unknown,unknown
critere_0523,Newly diagnosed treatment-naïve head and neck cancer patients eligible for surgery,unknown,false,unknown,unknown,unknown,unknown,false
critere_0524,Newly diagnosed treatment-naïve ovarian cancer patients eligible for surgery or neoadjuvant chemotherapy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0525,Newly diagnosed treatment-naïve sarcoma cancer patients (1) breast angiosarcoma or (2) uterine sarcoma eligible for surgery or systemic treatment,unknown,unknown,true,unknown,true,true,unknown
critere_0526,Newly diagnosed treatment-naïve triple-negative breast cancer patients eligible for surgery or neoadjuvant chemotherapy,unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0527,NIHSS score ≥ 5,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0528,No consent form,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0529,No contraindications to study medication as determined by the Investigator.,unknown,unknown,unknown,true,unknown,unknown,unknown
critere_0530,No coverage by a social security regime;,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0531,No evidence of distant metastasis at time of diagnosis;,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0532,No evidence of macroscopic distant metastatic disease or incurable locally advanced disease on staging scans conducted at any time since initial diagnosis.,unknown,false,true,unknown,true,true,false
critere_0533,No evidence of progression for at least 6 months on an AI/CDKi combination for advanced breast cancer.,true,false,unknown,unknown,unknown,true,false
critere_0534,No history of alcohol or other drugs of abuse.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0535,No social security cover,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0536,No vaccines given within 14 days of dosing.,unknown,false,true,unknown,unknown,false,false
critere_0537,Non epithelial breast cancer,unknown,false,unknown,unknown,unknown,true,false
critere_0538,Non-affiliation to a social security regimen or any other social protection regimen,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0539,Non-cancerous subject,false,false,true,true,true,true,false
critere_0540,Non-opposition of the subject to participate in the study.,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0541,Non-randomisation criteria: HVPG \< 12 mm Hg at the catheterism performed during the first follow-up visit,unknown,false,unknown,unknown,unknown,unknown,false
critere_0542,Non-smoking and no use of any tobacco or nicotine products (by declaration) for a period of at least 1 month prior to screening visit.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0543,Normal hearing,unknown,false,unknown,unknown,unknown,unknown,true
critere_0544,Normal hematologic status,unknown,false,true,unknown,true,true,false
critere_0545,Normal liver function,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0546,Normal MRI findings excepted intracranial TVS stenosis or IIH related abnormalities,unknown,false,true,unknown,unknown,unknown,false
critere_0547,Normal renal function,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0548,"Not covered by national health insurance,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0549,"Not requiring steroids up to 4 weeks before study treatment initiation, AND",unknown,false,unknown,unknown,unknown,false,false
critere_0550,Not using prescription medication 14 days prior to admission; and 7 days prior to admission for over the counter (OTC) medication/vitamins/supplements.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0551,Note: Participation in an observational study is allowed.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0552,obtaining a signed informed consent by a relative (or the person of trust) after clear and fair information about the study.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0553,Occurrence of a major complication (haemorrhagic or ischaemic) documented during the procedure of securing the aneurysm and endangering the short-term vital prognosis,unknown,unknown,true,unknown,true,true,unknown
critere_0554,On concomitant strong CYP3A4 inhibitors.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0555,On strong and moderate CYP3A4 inducers.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0556,One asthma exacerbation in the 4 weeks leading up to the inclusion visit or IGB placement.,unknown,unknown,unknown,unknown,unknown,true,true
critere_0557,"Ongoing condition that may lead to acute kidney injury or hypoxia: dehydration, severe infection, shock, cardiac decompensation, respiratory failure, or myocardial infarction within the past month",unknown,unknown,unknown,unknown,unknown,true,unknown
critere_0558,Ongoing participation in another interventional therapeutic trial,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0559,"Ongoing treatment with metformin, or discontinued for less than 3 months",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0560,Ongoing urinary tract infection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0561,"Opposition of the patient to participation in the study,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0562,Optic nerve atrophy,unknown,unknown,unknown,unknown,true,unknown,unknown
critere_0563,orthopedic devices or implants,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0564,Orthostatic hypotension,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0565,"Other liver disease: alcohol consumption exceeding 20 g / day for women and 30g / day in men, HBV, HCV, CBP, CSP, autoimmune hepatitis, hemochromatosis, Wilson's disease, alpha-1 antitrypsin.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0566,Other malignancy treated within the last 5 years (except non-melanoma skin cancer or in situ carcinoma of the cervix),unknown,true,unknown,unknown,unknown,true,true
critere_0567,"Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the patient inappropriate for entry into this study.",true,true,true,true,true,true,true
critere_0568,Outpatient consulting at the hospital on the day of inclusion,unknown,false,true,unknown,unknown,true,false
critere_0569,Outpatient consulting at the hospital on the day of inclusion,unknown,false,true,unknown,unknown,true,false
critere_0570,Over 18 and under 60 years of age,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0571,over 18 years old,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0572,Overweight (≥ 110 kg),unknown,false,false,unknown,unknown,unknown,false
critere_0573,Pacemaker,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0574,Pain preventing the test from being performed,true,false,true,true,true,true,unknown
critere_0575,Participant covered by or entitled to social security,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0576,Participant in good health,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0577,Participant under guardianship or curators,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0578,"Participant who received informed information about the study and co-signed, with the investigator, a consent to participate in the study",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0579,Participants affiliated to a social security scheme or beneficiaries of such a scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0580,Participants affiliated with a social protection system.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0581,Participants aged 65 years and older.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0582,Participants in a relationship with a person participating in the study.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0583,Participants included in phase I will not be included in phase II.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0584,Participants living in a dependent elderly care facility.,unknown,unknown,true,true,true,true,unknown
critere_0585,"Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).",true,false,unknown,unknown,true,unknown,false
critere_0586,"Participants of any sex and gender must be ≥ 18 years old, or older, at the time of signing the informed consent.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0587,Participants participating in another interventional research study.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0588,"Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.",true,unknown,unknown,unknown,true,unknown,true
critere_0589,Participants unable to provide informed written consent.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0590,Participants under administrative or judicial supervision,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0591,"Participants under legal protection (e.g., guardianship, tutorship).",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0592,"Participants under legal protection, guardianship, or trusteeship.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0593,"Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B birus (HBV) antiviral therapy for at least 4 weeks, and have undetectable HBV viral load prior to randomization",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0594,Participants who are staff members at the investigational site directly involved in conducting the study.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0595,Participants who donated blood or received blood or plasma derivatives in the 30 days preceding study drug administration.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0596,Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1,unknown,unknown,true,unknown,true,unknown,unknown
critere_0597,Participants who have AEs due to previous anticancer therapies must have recovered to ≤Grade 1 or baseline (except alopecia),unknown,false,unknown,true,true,unknown,false
critere_0598,Participants who have given the signed informed consent before carrying out any procedure related to the study.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0599,Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).,true,true,unknown,true,true,true,true
critere_0600,Participants with a life-threatening illness with a prognosis of less than 5 years.,true,false,unknown,unknown,unknown,unknown,unknown
critere_0601,"Participants with any abnormalities in clinical laboratory tests, and serology results, at screening, considered by the study physician as clinically significant.",true,false,true,true,unknown,true,false
critere_0602,"Participants with any acute medical situation (e.g., acute infection) within 48h of screening or start of dosing, which is considered of significance by the Investigator.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0603,Participants with CKD and eGFR ≥ 30 and \< 90 mL/min/1.73 m2 at screening,unknown,false,unknown,unknown,unknown,false,false
critere_0604,Participants with French as their mother tongue,false,false,true,true,true,true,false
critere_0605,"Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.",true,false,true,true,true,true,true
critere_0606,Participants with history of HTN and a SBP ≥ 130 mmHg at screening and ≥ 120 mmHg at the randomisation visit,false,false,unknown,unknown,unknown,unknown,false
critere_0607,Participants with normal or corrected vision,unknown,false,unknown,unknown,unknown,true,true
critere_0608,participation in another clinical interventional study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0609,Participation in another clinical trial or administration of an unapproved drug within the last 4 weeks before the screening date,unknown,false,false,unknown,false,false,false
critere_0610,Participation in another interventional research,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0611,Participation in another ongoing study if the study may interfere with participation in the protocol MAP-IRMaGe.,true,false,true,true,true,true,true
critere_0612,"Participation in another trial within 60 days prior to the enrolment visit or planned participation during the present trial period in another clinical study investigating a vaccine, drug, medical device, or medical procedure.",unknown,false,true,true,true,true,false
critere_0613,Participation in other intervention research,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0614,"Patient ≥ 18 years old,",false,false,unknown,unknown,unknown,unknown,false
critere_0615,Patient ≥18 years of age,false,false,unknown,unknown,unknown,unknown,false
critere_0616,Patient able to read and write in French and who have signed an informed consent form,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0617,Patient affiliated or beneficiary of a social security scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0618,Patient affiliated to a health insurance scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0619,Patient affiliated to a social health insurance plan (beneficiary or beneficiary's family),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0620,Patient affiliated to a social security organization,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0621,Patient affiliated to a social security system (excluding AME) or entitled to benefits.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0622,Patient affiliated to a social security system.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0623,Patient affiliated to or benefiting from a social security scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0624,"Patient aged 18 or over,",false,false,unknown,unknown,unknown,unknown,false
critere_0625,Patient agrees to come to the study visits within the protocol-specified delay,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0626,Patient allergic to Latex,unknown,false,unknown,true,unknown,unknown,false
critere_0627,Patient already engaged in a therapeutic protocol,unknown,false,true,true,true,true,false
critere_0628,"Patient and/or entourage who do not have access to teleconsultation, and/or can be reached remotely;",unknown,false,true,true,unknown,true,false
critere_0629,"Patient capable of passively opening the hand sufficient to grasp the glass when the gripping glove is put on, with the possibility of actively closing the hand;",unknown,false,unknown,unknown,true,unknown,true
critere_0630,Patient covered by the French social security system (for French patients).,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0631,Patient deprived of liberty (detained/incarcerated);,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0632,Patient deprived of liberty by judicial or administrative decision,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0633,Patient following any measures of legal presentation,unknown,false,true,true,true,unknown,false
critere_0634,Patient having given informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0635,Patient having received information about data collection and having signed and dated an Informed Consent Form,true,false,true,true,unknown,true,unknown
critere_0636,Patient having signed the informed consent for the present study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0637,"Patient identified by the network or referred by a healthcare professional,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0638,Patient in a medical emergency or immediate life-threatening situation,true,false,true,true,unknown,true,true
critere_0639,Patient in acute episode of their disorder according to the CGI Severity score,true,false,true,true,unknown,true,false
critere_0640,Patient in an exclusion period determined by a previous or ongoing study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0641,"Patient included in another interventional study which could interfere with the results of the study,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0642,Patient informed of the results of the preliminary medical examination,unknown,false,true,true,true,true,false
critere_0643,Patient insured under the French social security,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0644,Patient is at least 18 years of age.,false,false,unknown,unknown,unknown,unknown,false
critere_0645,Patient is unwilling to refrain from using prohibited medications during the clinical trial.,unknown,false,true,unknown,unknown,false,false
critere_0646,Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.,unknown,false,true,true,true,true,false
critere_0647,Patient must be affiliated to a Social Health Insurance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0648,Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives,true,false,unknown,unknown,unknown,false,false
critere_0649,Patient over 40 years,false,false,unknown,unknown,unknown,unknown,false
critere_0650,Patient participating at the same time in another study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0651,Patient participating in an interventional study involving psychotherapy or an experimental drug,unknown,false,unknown,unknown,unknown,unknown,false
critere_0652,Patient participating in another interventional clinical research protocol involving a drug or medical device,unknown,false,unknown,unknown,unknown,unknown,false
critere_0653,"Patient presenting retraction or stiffness of the fingers and wrist preventing complete extension of the long fingers and thumb, the wrist being at 15° extension;",unknown,false,false,unknown,unknown,false,true
critere_0654,"Patient receiving aspirin for another indication outside pregnancy,",true,false,true,true,true,true,false
critere_0655,Patient requiring neoadjuvant chemotherapy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0656,"Patient should agree to have one liver biopsy during the screening period (before randomization, the randomization will be permitted after at least a second reading performed by pathologist of CHRU Lille to confirm the histological diagnosis of NASH with advanced fibrosis (F3-F4)) for the diagnosis purpose (if no histological biopsy within 1 month before inclusion is available) and one at the end of the treatment period for assessment of the treatment effects.",unknown,false,true,false,false,false,false
critere_0657,"Patient suffering from a motor deficit of the upper limb resulting from an ischemic or hemorrhagic stroke, hemispheric or brainstem, confirmed by brain imaging ;",true,false,true,true,unknown,true,false
critere_0658,Patient suffering from lower limb weaknesses and / or deficiencies regardless of the cause,unknown,false,unknown,true,true,true,false
critere_0659,"Patient suffering from obesity defined by a BMI ≥ 30,",unknown,false,false,unknown,unknown,unknown,false
critere_0660,Patient taking part in another study with an impact on mortality or nutrition,true,false,true,true,true,true,true
critere_0661,Patient to be operated in first intention of a sleeve gastrectomy,unknown,false,unknown,true,true,true,false
critere_0662,Patient to have a 2-stage surgery (first sleeve gastrectomy then gastric bypass or Single Anastomosis Duodeno-Ileal bypass),unknown,false,true,unknown,unknown,true,false
critere_0663,Patient treated with aromatase inhibitors +/- LHRH agonist for at least 3 months with a planned remaining duration of at least 12 months,unknown,false,unknown,unknown,unknown,unknown,false
critere_0664,"Patient unable to actively extend long fingers (hand opening) to voluntarily grasp an empty glass (upper and lower diameter of 7 and 6 cm respectively, height of 12 to 15 cm, weight of 125g, identical to equipment used for ARAT), with a palmar grip (cylindrical grip), while the subject can hold the previously placed glass passively in the hand;",unknown,false,unknown,unknown,unknown,unknown,false
critere_0665,Patient unable to deliver his/her consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0666,Patient unable to follow the protocol for any reason,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0667,Patient unable to give consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0668,Patient unable to speak French,false,false,true,true,true,true,false
critere_0669,Patient under compulsory psychiatric care,unknown,false,unknown,unknown,unknown,unknown,false
critere_0670,Patient under guardianship or curatorship,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0671,"Patient under guardianship or tutorship, persons placed under the protection of justice or persons participating in another search including an exclusion period still in progress",unknown,false,unknown,unknown,unknown,unknown,false
critere_0672,"Patient under guardianship, curators or legal protection,P",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0673,Patient under judicial protection,unknown,false,unknown,unknown,unknown,unknown,false
critere_0674,"Patient under judicial protection (guardianship, curatorship, etc.) or safeguard of justice,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0675,Patient under legal protection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0676,Patient under legal protection.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0677,Patient under the justice protection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0678,Patient undergoing adjuvant treatment for breast cancer,unknown,false,unknown,unknown,unknown,true,false
critere_0679,"Patient undergoing bariatric surgery,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0680,Patient who agreed to participate by signing the informed consent of the study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0681,"Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception at the time of inclusion and up to 24 months after surgery",unknown,false,unknown,unknown,unknown,unknown,false
critere_0682,"Patient who has the capacity to understand the protocol and has given consent to participate in the research,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0683,Patient who is a beneficiary of or affiliated with a social security plan,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0684,Patient who suffered a stroke more than three months ago;,false,false,unknown,unknown,unknown,unknown,false
critere_0685,Patient who understands and speaks French.,unknown,false,unknown,unknown,unknown,true,unknown
critere_0686,"Patient with a cardiac or respiratory contraindication to physical exertion, at discretion of the physician",unknown,false,unknown,true,true,unknown,false
critere_0687,Patient with a motor handicap of grade 3 to 5 on the Rankin score,unknown,false,unknown,true,unknown,unknown,false
critere_0688,"Patient with a primary family caregiver at home (spouse, child) willing to participate in the study",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0689,Patient with a severe or fatal comorbidity that will likely prevent improvement or follow-up or that will render the procedure unlikely to benefit the patient.,unknown,false,true,true,true,true,false
critere_0690,"Patient with a smartphone, tablet and/or computer compatible with video taking and teleconsultation.",unknown,false,true,true,unknown,true,false
critere_0691,Patient with ALS who has already had at least two multidisciplinary assessments in the ALS center in Marseille with an evaluation by the clinical psychologist.,true,false,true,false,true,true,false
critere_0692,Patient with an active anterior shoulder elevation range of less than 15°;,false,false,true,true,true,true,false
critere_0693,Patient with contra-indication for bariatric surgery,true,false,unknown,true,unknown,unknown,false
critere_0694,Patient with elevated intracranial pressure defined as \> 25 cm H20 or 18 mmHg,unknown,false,unknown,unknown,unknown,unknown,false
critere_0695,Patient with histologically confirmed breast cancer,unknown,false,unknown,unknown,unknown,true,false
critere_0696,"Patient with idiopathic pulmonary hypertension (PH), familial PH, or PH associated with various pathologies (groups I to IV of the international classification)",true,false,unknown,unknown,unknown,unknown,false
critere_0697,"Patient with idiopathic pulmonary hypertension (PH), familial PH, or PH associated with various pathologies (groups I to IV of the international classification)",true,false,unknown,unknown,unknown,unknown,false
critere_0698,"Patient with limited active elbow extension, not allowing the ipsilateral knee to be reached with the hand, the subject being seated with the trunk vertical (approach limitation);",true,false,unknown,unknown,unknown,unknown,unknown
critere_0699,Patient with moderate or severe muscular spasticity of the wrist flexors and the long and short flexors of the fingers and thumb (Modified Ashworth Scale ≥ 3);,true,false,unknown,unknown,unknown,unknown,false
critere_0700,"Patient with one or several diagnoses of chronic psychiatric disorder (schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depression, borderline personality disorder) or a neurodevelopmental disorder (autism spectrum disorder) treated as an outpatient or in a day hospital",true,false,unknown,true,unknown,unknown,false
critere_0701,Patient with other upper limb deficiencies likely to influence participation;,true,false,unknown,unknown,true,true,false
critere_0702,Patient with pathologically confirmed TNBC (estrogen and progesterone receptor negative and HER2 negative);,unknown,false,unknown,unknown,unknown,unknown,false
critere_0703,"Patient with severe aphasia, Boston Diagnostic Aphasia Examination (BDAE) ≤ 3;",true,false,unknown,false,unknown,unknown,false
critere_0704,"Patient with significant proteinuria (\> 300mg/24 hours or a proteinuria/creatininuria ratio ≥ 30mg/mmol),",unknown,false,unknown,unknown,true,unknown,false
critere_0705,Patient with social security coverage.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0706,Patient with the ability to put on and remove the SaeboGlove® gripping glove with the help of a third person if necessary and/or available.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0707,"Patient without health coverage,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0708,Patient's foreseeable inability to participate in a clinical trial,unknown,false,unknown,true,unknown,unknown,true
critere_0709,Patients ≥ 18 years of age,false,false,unknown,unknown,unknown,unknown,false
critere_0710,Patients ≥18 years of age or over the legal age of consent in countries where that is greater than 18 years at the time of signature of the ICF.,true,false,true,true,true,true,false
critere_0711,Patients affiliated to a social security scheme,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0712,Patients aged 18 years and older ;,false,false,unknown,unknown,unknown,unknown,false
critere_0713,Patients considered in remission for at least 5 years after onset of treatment.,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0714,Patients included in the Fondation FondaMental cohort whose genetic analyses have revealed the need for comparative and functional genetic studies.,unknown,false,unknown,unknown,unknown,true,false
critere_0715,Patients must have had surgery achieving clear margins (as per local guidelines),unknown,false,true,true,unknown,true,false
critere_0716,Patients not affiliated to the Social Security System,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0717,"Patients on neuroleptics,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0718,Patients participating in other biomedical research or in a period of exclusion,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0719,Patients protected or unable to give consent according to Article L1121-8 of the French Public Health Code (CSP),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0720,Patients protected or unable to give consent according to Article L1121-8 of the French Public Health Code (CSP),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0721,"Patients receiving enforced cares (ASPDT, ASPPI, ASPDRE, etc.)",unknown,false,unknown,true,true,unknown,false
critere_0722,"Patients receiving standard endocrine therapy with aromatase inhibitors (letrozole, anastrazole, exemestane), tamoxifen, or combination of such for a minimum of 6 months\* and maximum of 7 years duration with an additional three years of endocrine therapy planned. Pre- or peri-menopausal patients may also receive GnRH analogues.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0723,Patients receiving State Medical Assistance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0724,Patients receiving topiramate in the previous month,unknown,false,unknown,unknown,unknown,unknown,false
critere_0725,Patients Treated and believed to be cured basal or squamous cell carcinoma of the skin or resected carcinoma of the cervix,unknown,false,unknown,unknown,unknown,true,false
critere_0726,"Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.).",unknown,false,unknown,unknown,unknown,unknown,false
critere_0727,Patients unable to give consent (under guardianship or curatorship),unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0728,Patients unable to undergo regular long-term surveillance.,unknown,false,unknown,true,unknown,unknown,false
critere_0729,Patients under guardianship or trusteeship.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0730,Patients under legal protective measures,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0731,"Patients who are unable to complete self-questionnaires (language barrier, etc.)",unknown,false,unknown,true,unknown,true,false
critere_0732,"Patients who had an acute cardiovascular episode, coronary Heart Disease (Angina pectoris, myocardial infarction, revascularization procedure), stroke or TIA (Transient Ischemic Attack) within the 6 months prior to screening Recent cardiovascular events (stroke, myocardial infarcts, etc...) in the past 6 months.",false,false,unknown,false,false,unknown,false
critere_0733,Patients who have signed a written informed consent form,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0734,"patients who underwent bariatric surgery in the weight stabilization phase (between 18 and 30 months after surgery) presenting dissatisfaction with their body image according to the BSQ (score ≥ 111), to be affiliated to the French social security system. The prior, free and informed consent of the patient shall be obtained.",unknown,false,true,false,true,false,false
critere_0735,"Patients who, after the nature of the study has been explained to them, have given written consent",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0736,Patients willing to have frequent blood tests.,unknown,false,true,unknown,unknown,unknown,false
critere_0737,Patients with a contraindication to amino acid infusion,unknown,false,unknown,true,unknown,unknown,false
critere_0738,"Patients with an intellectual disability (IQ\<70) estimated via the fNART (Mackinnon \& Mulligan, 2005)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0739,"Patients with any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule",unknown,false,true,unknown,true,unknown,false
critere_0740,"Patients with BMI \> 40 kg/m2 or BMI \> 35 kg/m2 associated with at least one comorbidity(s): hypertension, diabetes, cardiovascular disease, hyperlipidemia, sleep apnea, arthritis,hepatic steatosis.",true,false,true,true,unknown,unknown,false
critere_0741,"Patients with cancer with a risk of hypercalcemia (and associated hypercalciuria), linked to bone metastases.",unknown,false,unknown,unknown,unknown,true,false
critere_0742,Patients with current or history of thromboembolic events.,true,false,true,true,true,true,false
critere_0743,"patients with disabling nausea (Motion Sickness) from previous use of a virtual reality headset, patients who had from post-bariatric reconstructive surgery, epileptic patients, decompensation of a psychiatric pathology",unknown,false,true,true,true,true,false
critere_0744,Patients with epilepsy and migraine.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0745,Patients with gestational hypertension and/or preeclampsia from the 20th amenorrhea week until the 26th ± 2 amenorrhea week.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0746,"Patients with grade I obesity (BMI\> 30 kg/m² and \< 35 kg/m²) or morbid obesity (BMI\<40 or ≥35 kg/m² with serious physiological risks, as recommended by the French Health Authorities) with contraindications for or refusal of bariatric surgery.",true,false,true,true,true,true,false
critere_0747,Patients with health insurance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0748,Patients with high risk early stage breast cancer according to at least one of the following criteria:,unknown,false,unknown,unknown,unknown,true,false
critere_0749,Patients with known anterior dysphagia,unknown,false,unknown,unknown,true,true,false
critere_0750,"Patients with known glucose-6-phosphate dehydrogenase deficiency,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0751,"Patients with morphological contraindications to the use of the Atalante X exoskeleton (as per user's manual) with exceptions as follows: knee flessum of 20° authorized if sensibility is present; equinus of the ankle of 20° allowed regardless of presence or absence of sensibility, hip flessum of 20° allowed regardless of presence or absence of sensibility.",unknown,false,true,true,true,true,true
critere_0752,"patients with non-severe SAHa (WFNS I, II and III)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0753,"Patients with psychiatric follow-up, poor understanding of French or cognitive problems,",true,false,unknown,true,true,true,false
critere_0754,"Patients with renal failure (creatinine \> 1.5 mg/dl and/or creatinine clearance \< 60 mL/min, except if patient is already on hemodialysis)",unknown,false,unknown,unknown,true,false,false
critere_0755,"Patients with risk of aggravation of certain diseases under oestrogen treatment (MtF patients with uncontrolled diabetes with HBA1C \> 8%, patients with cholelithiasis, biliary lithiasis, systemic lupus erythematosus, severe asthma, severe arterial hypertension, severe migraines, otosclerosis, epilepsy not controlled by treatment).",true,false,true,true,true,true,true
critere_0756,"patients with severe SAHa (WFNS IV and V,) whose neurological examination is impossible because of coma (Glasgow coma score of 8 or less) or need for sedation at D3",unknown,false,false,false,false,false,false
critere_0757,Patients with uncontrolled asthma based on an ACQ score ≥1.5 despite inhaled corticosteroids ± long acting bronchodilators (LABA),unknown,false,unknown,unknown,unknown,unknown,false
critere_0758,"Patients with unstable psychiatric disorders,",unknown,false,unknown,true,true,unknown,false
critere_0759,Performance status ≤ 2 (according to WHO criteria),unknown,false,unknown,unknown,true,true,false
critere_0760,permanent contraindications to MRI,unknown,false,true,true,unknown,unknown,false
critere_0761,Person affiliated to or beneficiary of a social security system.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0762,"Person in a period of exclusion from another study,",unknown,false,unknown,unknown,unknown,true,unknown
critere_0763,Person subject to a measure of legal protection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0764,"Person under guardianship, curatorship, or safeguard of justice; or not subject to a social security plan,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0765,Person under legal protection,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0766,Persons deprived of liberty,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0767,Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body,true,false,false,false,false,false,false
critere_0768,Persons unable to adhere to abstinence from the use of drugs or alcohol the day or evening before experimental sessions,unknown,false,unknown,unknown,unknown,unknown,false
critere_0769,"Platelet count lower than 100,000 cells/microliter (dosage less than 6 months old),",unknown,false,unknown,unknown,unknown,false,false
critere_0770,Platelets \<125 000; TP \<80%; bilirubin \<20 mmol / l; albumin \<35 g / L.,unknown,false,unknown,unknown,unknown,false,false
critere_0771,Player under legal protection (guardianship/trusteeship) or deprived of liberty,unknown,false,unknown,unknown,unknown,unknown,false
critere_0772,Poor understanding of the French language,true,false,true,true,true,true,true
critere_0773,Poor understanding of the French language,true,false,true,true,true,true,true
critere_0774,Positive COVID-19 PCR test at screening visit.,unknown,false,true,unknown,unknown,true,false
critere_0775,"Positive serology for hepatitis B (HBsAg), C (anti-HCV antibodies) and HIV 1-2.",unknown,false,unknown,unknown,unknown,true,false
critere_0776,Positive serum pregnancy test (only if premenopausal).,unknown,false,unknown,unknown,unknown,unknown,false
critere_0777,Practice physical activity regularly (150 minutes/week of moderate physical activity according to the WHO),unknown,false,unknown,unknown,unknown,unknown,false
critere_0778,Pre- or postmenopausal women or men.,false,false,true,true,true,true,false
critere_0779,Pre-admission modified Rankin score of 4 or 5,unknown,false,unknown,unknown,unknown,unknown,false
critere_0780,Pregnancies complicated by major fetal abnormality identified at the first-trimester ultrasound if performed before randomization,unknown,false,unknown,false,unknown,unknown,false
critere_0781,Pregnancy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0782,Pregnancy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0783,Pregnancy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0784,Pregnancy between 11 and 14 WG,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0785,Pregnancy in progress,unknown,false,unknown,unknown,unknown,unknown,false
critere_0786,Pregnancy or breastfeeding in progress,unknown,false,unknown,unknown,unknown,unknown,false
critere_0787,Pregnancy or breastfeeding or Women of childbearing age without effective contraception (a pregnancy test will be done),unknown,false,unknown,unknown,unknown,unknown,false
critere_0788,Pregnancy positive test (βHCG test) or pregnancy or breastfeeding.,unknown,false,true,unknown,unknown,unknown,false
critere_0789,"Pregnancy test will be repeated on day 1, before the first dose of WOO treatment.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0790,"pregnancy, breastfeeding",unknown,false,unknown,unknown,unknown,unknown,false
critere_0791,"Pregnancy, parturiency or breastfeeding",unknown,false,unknown,unknown,unknown,unknown,false
critere_0792,Pregnancy: if a woman is of childbearing potential a urine or serum beta HCG test is positive,unknown,false,unknown,unknown,unknown,unknown,false
critere_0793,Pregnant and/or breastfeeding women,unknown,false,unknown,true,unknown,unknown,false
critere_0794,Pregnant or breast-feeding women,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0795,Pregnant or breast-feeding women;,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0796,Pregnant or breastfeeding female participants.,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0797,Pregnant or breastfeeding patient.,unknown,false,unknown,true,unknown,unknown,false
critere_0798,Pregnant or breastfeeding woman,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0799,Pregnant or breastfeeding women,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0800,Pregnant or breastfeeding women,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0801,"Pregnant or breastfeeding women,",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0802,Pregnant or breastfeeding women.,unknown,false,unknown,true,unknown,unknown,false
critere_0803,Pregnant or lactating women,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0804,Pregnant or lactating women according to article L1121-5 of the CSP,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0805,Pregnant or lactating women according to article L1121-5 of the CSP,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0806,Pregnant or nursing patient,unknown,false,unknown,true,true,unknown,false
critere_0807,"Pregnant or women of childbearing age who were not using contraception (oral diagnosis),",true,false,unknown,true,unknown,unknown,false
critere_0808,Pregnant patient between 10 and 19 weeks of gestation + 6 days,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0809,Pregnant woman,false,false,true,true,true,true,false
critere_0810,Pregnant woman,false,false,true,true,true,true,false
critere_0811,"Pregnant, breast-feeding or parturient woman",unknown,false,unknown,true,unknown,unknown,false
critere_0812,"Pregnant, lactating and parturient women",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0813,"Pregnant, parturient or breast-feeding woman,",unknown,false,unknown,true,unknown,unknown,false
critere_0814,"Premenopausal women age ≥18 years, premenopausal status defined as:",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0815,Presence of a Proton-Pump Inhibitors treatment,unknown,false,unknown,unknown,unknown,unknown,false
critere_0816,"Presence of at least one measurable lesion according to Response evaluation criteria in solid tumors (RECIST) 1.1, as determined by the local site investigator/radiology assessment.",true,false,true,true,true,true,false
critere_0817,"Presence of comorbidities or medical conditions that may interfere with study data,",unknown,false,true,true,true,true,false
critere_0818,Presence of moderate or severe edema localized to the wrist and hand;,true,false,unknown,true,true,true,false
critere_0819,"Presence of other neurological, muscular or osteoarticular conditions altering upper limb function,",true,false,true,true,true,unknown,false
critere_0820,Presence of other psychiatric pahtologies,unknown,false,unknown,unknown,true,unknown,false
critere_0821,"Presence of pathologies interfering in a major way with vascular parameters: known multicomplicated diabetes treated before pregnancy, hypercholesterolemia known (or LDL\>130 mg/dl), connectivitis, proven cardiovascular disease (ischemic heart disease, stroke, arteriopathy of the lower limbs, heart failure), pre-existing known renal failure (MDRD \<60 ml/min) and/or pre-existing proteinuria ≥ 300 mg/24h).",true,false,false,false,true,false,false
critere_0822,Present or past eating disorders.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0823,Presenting a depressive episode of moderate intensity according to the Diagnostic and Statistical Manual (DSM)-V,unknown,false,unknown,unknown,unknown,unknown,false
critere_0824,"Presenting disabling vaginal dryness symptoms despite well-administered local moisturizing treatment, attested by a vaginal dryness score ≥3",unknown,false,unknown,false,unknown,unknown,false
critere_0825,"Presenting the criteria for gender dysphoria according to the DSM5 assessed by at least two child psychiatric interviews at least six months apart where the diagnosis of gender dysphoria was clinically established and that of associated autism spectrum disorder refuted and/or associated cognitive impairment, confirmed by specific scales (Gender Identity / Gender Dysphoria Questionnaire for Adults and Adolescents (GIDYQ-AA) and Utrecht Gender Dysphoria Scale (UGDS))",true,false,unknown,true,false,true,false
critere_0826,"Pressure Ulcer of Grade I or higher according to the NPUAP International Pressure Ulcer Classification System- EPUAP, in areas of contact with the Atalante X system",unknown,false,unknown,unknown,true,unknown,false
critere_0827,Previous gastric bypass surgery AAP-DGOS PHRC-N 22_0175 CHU DE MONTPELLIER Pr Costalat Vincent/Pr Ducros Anne Version n°2.2 date 25/03/2025 Page 28 sur 63,unknown,false,unknown,unknown,unknown,unknown,false
critere_0828,Previous history of bariatric surgery (except gastric ring removed for more than 3 years).,unknown,false,unknown,unknown,unknown,unknown,false
critere_0829,Previous inclusion in the trial,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0830,Previous nasal surgery or nasal cauterization.,unknown,false,unknown,true,true,unknown,false
critere_0831,Previous systemic or local treatment for the primary breast cancer currently under investigation.,unknown,false,unknown,true,true,true,false
critere_0832,"Primary surgery (no other treatment prior to surgery) A. Four or more involved axillary lymph nodes or positive supraclavicular lymph node at diagnosis, or",unknown,true,true,true,true,true,true
critere_0833,Primary tumor removed by conservative surgery with negative margins;,unknown,false,unknown,unknown,unknown,true,false
critere_0834,"Prior progression of disease on abemaciclib, fulvestrant, or other selective estrogen receptor degrader (SERD) therapy.",true,false,true,unknown,unknown,true,false
critere_0835,Prothrombin ratio \< 50 %,unknown,false,unknown,unknown,unknown,false,false
critere_0836,Provide written informed consent and agree to comply to the study protocol prior to enrolment.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0837,"Provision of a fresh tumor sample of the lesion that will be injected first and, whenever possible, from another lesion that is planned to be injected, at baseline and be willing to supply new tumor samples from a biopsy during treatment.",false,false,unknown,false,false,false,false
critere_0838,Psychiatric contraindication,unknown,false,unknown,unknown,unknown,unknown,false
critere_0839,Psychiatric disorders,unknown,false,unknown,true,true,unknown,false
critere_0840,Pure intraventricular haemorrhages,unknown,false,unknown,unknown,true,unknown,false
critere_0841,"Radiotherapy within 30 days prior to Visit 0 (Day 1) except in case of localized radiotherapy for analgesic purposes or for lytic lesions at risk of fracture, which can then be completed within 7 days prior to Visit 0 (Day 1). Subjects must have recovered from radiotherapy toxicities prior to Visit 0 (Day 1).",unknown,false,unknown,unknown,false,true,false
critere_0842,Randomization must be conducted within 16 weeks from surgical resection,unknown,false,unknown,unknown,unknown,unknown,false
critere_0843,"Read, understood, and signed an ICF before any investigational procedure(s) are performed.",false,false,false,false,false,false,false
critere_0844,Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. Administration of killed vaccines are allowed,unknown,false,true,unknown,false,false,false
critere_0845,Received an immunosuppressive therapy for underlying disease or a treatment with immunosuppressive or cytotoxic drugs or a cancer chemotherapy or radiation therapy within the previous 36 months.,false,false,false,false,false,false,false
critere_0846,"Received anticancer therapy in the adjuvant phase including but not limited to chemotherapy, small molecule anticancer drugs, poly (adenosine diphosphate ribose) polymerase (PARP) inhibitors, ADCs, and/or immunotherapy, with the exception of adjuvant radiation therapy",unknown,false,unknown,unknown,unknown,true,false
critere_0847,Received any GnRH/LHRH analog within 12 months prior to randomization,unknown,false,unknown,unknown,unknown,unknown,false
critere_0848,"Received at least 3 doses of a COVID-19 mRNA vaccine, last booster dose received at least 6 months prior to trial vaccine administration OR 2 doses of a COVID-19 mRNA vaccine and confirmed SARS-CoV-2 infection at least 6 months prior to inclusion in the trial.",unknown,false,false,unknown,unknown,false,false
critere_0849,"Received drugs such as corticosteroids at a dosage \> 10 mg prednisone equivalent/day or inhalers corticosteroids, within 3 months prior to inclusion (excluding corticosteroid topical preparations for cutaneous application).",unknown,false,false,unknown,unknown,false,false
critere_0850,Received immunoglobulin or other blood products within three months prior to inclusion or planned administration before the trial completion.,unknown,false,true,unknown,false,false,false
critere_0851,"Received influenza vaccination within 14 days prior to trial vaccination, or any other licensed vaccine within 4 weeks prior to study vaccination.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0852,Received prior radiotherapy within 3 weeks of start of study intervention or required corticosteroids for radiation related toxicities that cannot be discontinued before the first dose of study intervention,unknown,false,false,unknown,false,false,false
critere_0853,Received prior treatment with a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) or a topoisomerase I inhibitor-containing ADC,unknown,false,unknown,unknown,unknown,unknown,false
critere_0854,"Recent history of venous (pulmonary embolism, phlebitis) or arterial (myocardial infarction, unstable angina, stroke, transient ischemic attack), thrombotic event ≤ 3 months.",false,false,unknown,true,unknown,unknown,false
critere_0855,Recent serious injury,true,false,true,true,unknown,true,unknown
critere_0856,"Recovered from any previous therapy-related toxicity to ≤ Common Terminology Criteria for Adverse Events (CTCAE) Grade 1 at start of treatment (except for alopecia, stable sensory neuropathy, and hypothyroidism (patients on thyroid replacement therapy) which must be ≤ CTCAE Grade 2).",unknown,false,false,false,false,false,false
critere_0857,Referral from other hospitals,true,false,unknown,true,unknown,true,false
critere_0858,"Refractive error greater ±8 sphere or more than ±3 in cylinder in either eye if there are abnormalities in funduscopy (optic disc tilt, staphyloma), previous glaucoma, other disorders causing visual loss",true,false,true,true,true,true,false
critere_0859,Refusal of parents (or legal representative) to sign the consent form;,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0860,"Refusal of the minor to take part, even if the legal representatives want the player to take part in the study Refusal to perform the test",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0861,Refusal to participate in the study on the part of the adolescent or one of the holders of parental authority (both holders and the adolescent must sign a written consent after receiving appropriate information).,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0862,"Refusal to sign the consent form,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0863,Regional lymph node pN0 to pN3;,unknown,false,unknown,unknown,unknown,unknown,false
critere_0864,Registration with the French healthcare system,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0865,"Regular consumption of tobacco or alcohol,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0866,Regular intake of dietary supplements or vitamin supplements in the last three months,unknown,false,unknown,unknown,unknown,unknown,false
critere_0867,Regular use of medications that impact the central nervous system,true,false,true,true,true,true,false
critere_0868,"Regular use of medications, such as opioids and antidepressants, including SSRIs and tricyclic antidepressants",unknown,false,unknown,unknown,unknown,unknown,false
critere_0869,Relative of patient included in the Fondattion FondaMental cohort,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0870,"Requiring inpatient or outpatient hospitalization in a rehabilitation center,",true,false,true,true,true,true,false
critere_0871,Resting heart rate ≥40 bpm.,unknown,false,unknown,unknown,true,unknown,false
critere_0872,retinal operation,unknown,false,unknown,true,unknown,unknown,false
critere_0873,Right handed,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0874,Right-handed.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0875,"Schizophrenia, schizoaffective disorder or persistent delusional disorder (DSM-5)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0876,Screening supine BP ≥145 mm Hg (systolic) or ≥90 mm Hg (diastolic),unknown,false,unknown,false,unknown,unknown,false
critere_0877,Secondary,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0878,septic shock,unknown,false,unknown,unknown,unknown,unknown,false
critere_0879,"Serious infection requiring oral or IV antibiotics, or other clinically significant infection within 14 days prior to screening.",unknown,false,true,unknown,unknown,unknown,false
critere_0880,"Serum sodium \< 135 mmol/L at the Screening Visit, determined as per central laboratory.",unknown,false,unknown,unknown,unknown,false,false
critere_0881,Serum total bilirubin \> 50 µmol/L,unknown,false,unknown,unknown,unknown,false,false
critere_0882,"Severe acute or chronic medical or laboratory abnormality that may increase the risk associated with study participation or seralutinib administration, unless associated with an ongoing AE and discussed with the Sponsor's medical monitor (MM) (or designee).",true,true,true,true,unknown,true,true
critere_0883,Severe and unstable eating disorders,unknown,false,unknown,unknown,unknown,unknown,false
critere_0884,"Severe aphasia limiting ability to express needs or to fulfil questionnaires, at the discretion of the physician.",true,false,true,true,true,true,false
critere_0885,"Severe autism Spectrum Disorder (clinical screening, confirmed in cases of doubt by the Social Responsiveness Scale (SRS) Raw-score \> 76, carried out as part of usual care in cases of clinical evidence,",unknown,false,true,true,true,false,false
critere_0886,"Severe cardiac impairment,",unknown,false,unknown,true,unknown,unknown,false
critere_0887,"Severe cardiac, hepatic or renal failure or ischemic heart disease, due to the risk of severe complications characterized by edema, with or without congestive heart failure.",true,false,true,true,true,true,false
critere_0888,Severe chronic cardiac insufficiency (grade III and IV of NYHA classification).,unknown,false,unknown,false,unknown,unknown,false
critere_0889,"Severe chronic kidney disease defined as estimated glomerular filtration rate \< 30 mL/min/1,73m2 using the MDRD-6 formula",unknown,false,unknown,unknown,unknown,unknown,false
critere_0890,Severe chronic respiratory disease.,unknown,false,unknown,true,true,unknown,false
critere_0891,"Severe cognitive or psychiatric disorders, chronic alcoholism, drug addiction 8.2 Severe and unstabilised eating disorders: bulimia or history of anorexia 8.3 History of gastric surgery including the ring insertion 8.4 Haemostasis disorders 8.5 Anticoagulant or non-steroidal anti-inflammatory medicines 8.6 Severe liver disease 8.7 Pregnancy or desire to become pregnant or breastfeeding 8.8 Anticipated failure to comply with prolonged medical follow-up 8.9 Large hiatal hernias \> 5 cm, inflammatory (Crohn's) or stenosing small bowel disease, pyloric stenosis and structural abnormalities of the digestive tract 8.10 Systemic lupus erythematous 8.11 Severe oesophagitis and active gastroduodenal ulcer 8.12 Silicone allergy",true,false,false,false,true,false,false
critere_0892,Severe hearing loss,unknown,false,unknown,unknown,true,unknown,false
critere_0893,Severe heart failure (NYHA III_IV),unknown,false,unknown,true,unknown,unknown,false
critere_0894,"Severe hepatic insufficiency,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0895,Severe psychiatric disorder or other illness that may disrupt the study follow-up or to invalidate the proper understanding of the protocol information and the informed consent,true,true,true,true,true,true,true
critere_0896,"Severe renal impairment,",unknown,false,unknown,unknown,true,unknown,false
critere_0897,Severe untreated chronic depression,unknown,false,unknown,unknown,unknown,true,false
critere_0898,Severity score measures using the Boston Diagnostic Aphasia Examination battery scale corresponding to the mild or moderate level (score greater than or equal to 2),unknown,false,unknown,unknown,unknown,unknown,false
critere_0899,Sexually active premenopausal women and men unwilling to use double-barrier contraception.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0900,Shoulder and cervical spine surgery less than 6 months old.,false,false,unknown,unknown,unknown,unknown,false
critere_0901,Signed and dated written Informed consent form (ICF) in accordance with International Council for Harmonisation-Good Clinical Practice (ICH-GCP) and local legislation prior to admission to the trial.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0902,Signed informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0903,Signed informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0904,Signed informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0905,Signed Informed Consent form,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0906,Signed the written informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0907,"Significant cognitive impairments: inability to understand simple instructions or give consent of any kind (not included if: LAST scores \< 5/7 in comprehension, and if YES/NO answers are unreliable),",true,false,unknown,false,true,true,false
critere_0908,"Significant pain on mobilization of the wrist or elbow (VAS \> 5/10),",true,false,true,true,true,true,false
critere_0909,Signing of free and informed consent,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0910,Simultaneous enrollment in another clinical trial.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0911,Simultaneous participation in any other research protocol,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0912,Simultaneous participation in any other research protocol,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0913,Singleton pregnancy,unknown,false,unknown,unknown,unknown,unknown,false
critere_0914,Smokers \>10 cigarettes per day,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0915,Smoking \> 10 packs/year (PA),unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0916,Smoking ≥ 5 cigarettes/day during the past 6 months.,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0917,Solid organ transplantation,unknown,false,unknown,unknown,unknown,unknown,false
critere_0918,Stable and maximum tolerated dose of an ACE inhibitor or an ARB (not both) for at least 4 weeks prior to Screening Visit,unknown,false,unknown,unknown,unknown,unknown,false
critere_0919,Stable body weight (weight change +/- 5 % for 3 months prior to screening),unknown,false,unknown,false,false,true,false
critere_0920,Stable medical condition over the previous 1 month.,true,false,unknown,unknown,true,unknown,false
critere_0921,Stage IV (metastatic) breast cancer.,unknown,false,unknown,unknown,unknown,true,false
critere_0922,Start of disorder (defined by the occurrence of the first thymus episode: characterized depressive disorder or maniac episode with or without mixed characteristics) for 5 years or more,false,false,true,unknown,false,unknown,false
critere_0923,stroke \< 20 days,false,false,unknown,unknown,unknown,unknown,false
critere_0924,Stroke less than 2 days old,true,false,unknown,unknown,unknown,unknown,false
critere_0925,"Stroke, transient ischaemic cerebral attack, valve implantation or valve replacement, carotid surgery, or carotid angioplasty, acute coronary syndrome, or hospitalisation for worsening heart failure within previous 3 months prior to randomisation.",false,false,unknown,false,false,false,false
critere_0926,Subject affiliated to or beneficiary from a French social security regime,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0927,Subject affiliated to the social security system,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0928,"Subject being in the exclusion period of another study or provided for by the ""National Volunteer File""",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0929,Subject beneficiary from a legal protection regime,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0930,Subject is ≥ 18 years old at inclusion.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0931,Subject not covered by social security,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0932,"Subject protected according to the French Public Health Code (e.g. patients under law protection, prisoners, pregnant, parturient or lactating women, and patients under guardianship/curatorship)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0933,Subject under measure of protection or guardianship of justice,unknown,false,unknown,unknown,true,true,false
critere_0934,Subject undergoing bariatric surgery (OB group) or abdominal surgery (group NO),unknown,false,unknown,true,unknown,unknown,false
critere_0935,Subject unlikely to cooperate or low cooperation stated by investigator,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0936,Subject who are in a dependency or employment with the sponsor or the investigator,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_0937,Subject with a BMI greater than 35 kg / m2 (group OB) or less than 30 kg / m² (group NO),unknown,false,unknown,unknown,unknown,unknown,false
critere_0938,Subject with an infection or inflammatory syndrome (CRP\> 10 mg / L and / or white blood cells\> 12000 / mm3),unknown,false,false,unknown,unknown,false,false
critere_0939,"Subject with definite diagnosis of IIH satisfying the modified Dandy criteria (A to E) ) at the time of initial diagnosis, under BMM including ACZ for more than 1 year",false,false,unknown,false,unknown,true,false
critere_0940,Subject with intracranial TVS stenosis on dominant transverse sinus and hypoplastic contralateral one (or bilateral TVS stenosis) diagnosed on MRI,true,false,true,unknown,unknown,unknown,false
critere_0941,"Subjects abled to understand the information note and abled to sign the consent form,",unknown,false,unknown,unknown,unknown,true,unknown
critere_0942,"Subjects may have received 1 cytotoxic chemotherapy regimen in the metastatic disease setting prior to study entry, but must have recovered from chemotherapy acute toxicity excluding alopecia and Grade 2 peripheral neuropathy.",unknown,false,unknown,false,true,false,false
critere_0943,Subjects must be able to attend all scheduled visits and to comply with all trial procedures,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0944,Subjects must be covered by public health insurance,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0945,Subjects must have completed a qualifying last visit in a prior seralutinib PAH study on investigational product (IP) and in accordance with the protocol.,unknown,false,unknown,unknown,unknown,unknown,false
critere_0946,Subjects subjected to a social security plan.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0947,"Subjects suffering from (according to DSM IV criteria) : Bipolar disorder, Unipolar depression, Schizophrenia, Autism spectrum disorder",unknown,false,unknown,unknown,unknown,unknown,false
critere_0948,"Subjects undergoing energy restriction or physical activity weight loss program at the time of inclusion or within the past 6 months,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0949,Subjects with a known hypersensitivity to fulvestrant or to any of the excipients,unknown,false,unknown,unknown,unknown,unknown,false
critere_0950,"Subjects with high levels of physical activity (\> 5 h of exercise per week),",unknown,false,unknown,unknown,unknown,unknown,false
critere_0951,"Subjects with stable body weight (variation \< 3% of body weight) until at least 6 months,",unknown,false,unknown,unknown,unknown,unknown,false
critere_0952,Substance abuse,unknown,false,unknown,unknown,unknown,unknown,false
critere_0953,"Surgery within the last 3 months,",unknown,false,false,false,false,false,false
critere_0954,"Systolic blood pressure \> 180 mmHg, or DBP \> 110 mmHg at screening.",unknown,false,unknown,unknown,unknown,unknown,false
critere_0955,Taking a probiotic supplement during the last month prior to inclusion,unknown,false,unknown,unknown,unknown,unknown,false
critere_0956,"Taking medication that may interfere with study results,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0957,tDCS contraindication,unknown,false,unknown,true,unknown,unknown,false
critere_0958,Temperature ≥ 38.0°C or symptoms of acute self-limiting illness such as upper respiratory tract infection or gastroenteritis within three days prior to vaccine dose.,false,false,false,false,false,false,false
critere_0959,The parents (or legal representative) must have signed the consent form;,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0960,The patient agrees to the submission of tumor (diagnostic pre-treatment core biopsy and post-treatment re-biopsy) and blood samples for central pathology review (CPR) and for translational studies as part of this protocol.,unknown,false,unknown,true,unknown,true,false
critere_0961,The patient has already been included in the study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0962,The patient has already been included in the study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0963,"The patient has been informed of and agrees to data transfer and handling, in accordance with national data protection guidelines.",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0964,The presence of other significant dermatological conditions that could interfere with the evaluation of the study treatment's safety and efficacy.,unknown,false,unknown,true,unknown,unknown,false
critere_0965,Transaminases \> 5 ULN,unknown,false,false,unknown,unknown,true,false
critere_0966,treated by ECT or rTMS or tDCS for the current eposide,true,false,unknown,true,unknown,unknown,false
critere_0967,"Treated cohort: the child participated in the OTBB3 study and is aged 16±4 months at inclusion,",unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0968,"treated with chemotherapy for lung , breast, colon or prostate cancer",unknown,false,unknown,unknown,unknown,true,false
critere_0969,"Treated with insulin, GLP-1 analogs, acarbose, corticoids, beta-blockers.",unknown,false,unknown,unknown,unknown,true,false
critere_0970,"Treated with lipid lowering drugs (fibrates, statins, anti-PCSK9, ezetimibe, cholestyramine) within the last 6 weeks before study entry",unknown,false,unknown,unknown,unknown,unknown,false
critere_0971,Treatment by biotherapy within the 12 months after inclusion,unknown,false,false,false,false,false,false
critere_0972,Treatment with any investigational agents within 30 days prior to expected start of trial treatment.,unknown,false,false,false,false,false,false
critere_0973,"Treatment with carvedilol (≥ 6,25 mg/day) at a stable dose for at least one month",unknown,false,false,false,true,false,false
critere_0974,Treatment with GLP1 (glucagon-like peptide) analogue or insulin,unknown,false,unknown,unknown,unknown,unknown,false
critere_0975,"Treatment with nucleoside/nucleotide analogue for HBV, or direct-acting antiviral treatment for HCV, started for less than 6 months",unknown,false,true,unknown,true,true,false
critere_0976,"Treatment with orlistat Xénical® or GLP1 analogues or regular consumption of narcotics (heroin, cocaine and amphetamines). Analgesic treatments, including level 3, are authorized during the study.",true,false,true,false,false,false,false
critere_0977,Treatment with statins started or discontinued for less than 3 months,unknown,false,true,unknown,true,true,false
critere_0978,Treatment with strong CYP3A4 inhibitors or inducers within 14 days or 5 drug elimination half-lives (whichever is longer) prior to initiation of study treatment.,unknown,false,false,false,false,false,false
critere_0979,Tumor types :,unknown,false,unknown,unknown,unknown,true,false
critere_0980,"Two or more diuretic agents (loop diuretic, thiazides and thiazide-like diuretics)",unknown,false,unknown,unknown,unknown,unknown,false
critere_0981,Type 2 diabetes mellitus with HbA1c \> 7.5 %,unknown,false,unknown,unknown,unknown,false,false
critere_0982,"Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,",unknown,false,unknown,unknown,true,true,false
critere_0983,Uncontrolled high blood pressure.,true,false,unknown,unknown,unknown,unknown,false
critere_0984,Uncontrolled office BP (\>140 and/or 90 mmHg) confirmed by home blood pressure monitoring (\>135/85 mmHg),unknown,false,unknown,false,unknown,unknown,false
critere_0985,Uncorrected sensory deficits,unknown,false,unknown,true,unknown,true,unknown
critere_0986,Under antidepressant treatment,unknown,false,unknown,unknown,unknown,unknown,false
critere_0987,under mood stabilizer and/or antiepileptic,unknown,false,unknown,unknown,unknown,unknown,false
critere_0988,Unstabilised psychiatric illness,unknown,false,unknown,unknown,unknown,unknown,false
critere_0989,"Untreated cohort: the child has never received OT, is aged 30±6 months at inclusion (in order to maximise the number of children in the untreated cohort) and is followed in France.",unknown,false,unknown,unknown,true,unknown,false
critere_0990,"Unwilling or unable to comply with all scheduled visits, treatment plan, laboratory tests and other study procedures and the restrictions described in the protocol.",unknown,false,true,unknown,true,true,false
critere_0991,Unwilling or unable to comply with the protocol.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0992,Urine albumin creatinine ratio \> 200 mg/g (22.6 mg/mmol) and \< 5000 mg/g (565 mg/mmol) at screening,unknown,false,unknown,unknown,unknown,unknown,false
critere_0993,Use of dietary supplements,unknown,false,unknown,unknown,unknown,unknown,false
critere_0994,Usual french language,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_0995,Vaccination with a COVID-19 vaccine other than mRNA vaccine.,unknown,false,true,unknown,unknown,true,false
critere_0996,Validation of the surgical intervention in a multidisciplinary consultation meeting,true,false,unknown,true,true,true,false
critere_0997,Virologically documented (PCR or antigenic test) history of COVID-19 in the past 3 months.,unknown,false,false,unknown,false,false,false
critere_0998,Visceral crisis in need of cytotoxic chemotherapy as assessed by the investigator.,unknown,false,unknown,true,unknown,true,false
critere_0999,"Voluntary weight loss in the last 6 months,",unknown,false,unknown,unknown,unknown,true,unknown
critere_1000,Volunteer patients will be recruited as part of their follow-up at the CHU. Their pathology will be in agreement with that of the research protocol to be optimized.,true,false,true,true,true,true,false
critere_1001,Vulnerable persons according to article L1121-6 of the CSP,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1002,Vulnerable persons according to article L1121-6 of the CSP,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1003,"wearer of pacemaker or cardiac defribrillator or vascular clip or prosthesis cardiac or insulin pump or implanted device to deliver medication or hearing implant or prosthesis or vascular shunt or paragraph or screws, plate metal or tattoo or piercing or implanted metal object or lead shot hunt",unknown,false,unknown,true,unknown,true,false
critere_1004,Who have already undergone a psycho-education or therapeutic patient education programme regarding depression.,unknown,false,unknown,unknown,unknown,true,false
critere_1005,"Whose indication for hormonal transition has been validated in a multidisciplinary consultation meeting after at least one consultation with the pediatric endocrinologist with clinical examination, blood pressure measurement, and information on hormonal treatments in the context of gender dysphoria.",true,false,true,true,true,unknown,false
critere_1006,Whose state of health is compatible with follow-up by their GP (possibility of occasional advice from a psychiatrist).,unknown,false,true,unknown,unknown,true,false
critere_1007,Whose state of health requires follow-up by a psychiatrist,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_1008,"Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures",unknown,false,true,unknown,true,true,false
critere_1009,Willingness and ability to comply with the treatment and follow-up visits.,true,false,true,true,true,true,false
critere_1010,"Willingness to refrain from current treatments, in compliance with the list of prohibited medications.",unknown,false,unknown,unknown,unknown,unknown,false
critere_1011,With a prescription for an antidepressant started less than 2 months before inclusion in the trial.,unknown,false,false,unknown,unknown,false,false
critere_1012,"With a spontaneous ICH, i.e. non traumatic",true,false,unknown,unknown,true,unknown,false
critere_1013,"With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke",true,false,unknown,true,true,unknown,false
critere_1014,WOCBP who are not abstinent and intend to be sexually active with a non-sterilized male partner must be willing to use a highly effective method of contraception from consent through 30 days following the last administration of IP.,unknown,false,unknown,unknown,true,unknown,false
critere_1015,"Woman deprived of liberty, under guardianship or trusteeship.",unknown,false,unknown,unknown,unknown,unknown,false
critere_1016,Woman of childbearing potential who has a positive serum pregnancy test (within 72 hours) prior to the start of treatment.,unknown,false,unknown,unknown,unknown,unknown,false
critere_1017,"woman of childbearing without a highly effective contraceptive measure (combined or progestogen-only hormonal contraception associated with inhibition of ovulation, intrauterine device or intrauterine hormone-releasing system)",unknown,true,unknown,unknown,unknown,unknown,false
critere_1018,Women aged 18 and over;,false,false,true,true,true,true,false
critere_1019,Women between 18 and 60 years old (including 60),false,false,true,true,true,true,false
critere_1020,Women of childbearing potential (WOCBP) must have a negative urine or serum pregnancy test at enrollment visit before first administration of Investigational Product (IP) in this study.,unknown,false,unknown,unknown,unknown,unknown,false
critere_1021,Women of childbearing potential must use highly effective contraceptive methods during the treatment period and for 10 days after the final dose.,unknown,false,unknown,unknown,unknown,unknown,false
critere_1022,Women taking low-dose aspirin regularly before pregnancy (except ART indication),unknown,false,unknown,unknown,unknown,unknown,false
critere_1023,"Women under the protection of justice,",false,false,true,true,true,true,false
critere_1024,Women who are breast feeding,unknown,false,unknown,true,unknown,unknown,false
critere_1025,Women who are pregnant or in the period of lactating.,unknown,false,unknown,unknown,unknown,unknown,unknown
critere_1026,"Women who are pregnant, breastfeeding, or have given birth in the last 6 months",unknown,false,unknown,unknown,unknown,unknown,unknown
critere_1027,Women with TNBC breast cancer who meet the following criteria:,unknown,false,unknown,unknown,unknown,unknown,false
critere_1028,Written Informed Consent (IC) must be signed and dated by the patient and the Investigator prior to randomization.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1029,Written informed consent obtained from the participant,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1030,Written informed consent obtained from the participant.,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1031,"Written informed consent obtained from the patient prior to performing any protocol-related procedures, including screening biopsy, blood samples and questionnaires",unknown,false,false,false,false,false,false
critere_1032,Written informed consent to participate in the study,unknown,unknown,unknown,unknown,unknown,unknown,unknown
critere_1033,Written informed consent to participate in the trial and to donation of tissue and blood samples,unknown,false,unknown,unknown,unknown,unknown,false
critere_1034,Younger than 18 years old,false,false,unknown,unknown,unknown,unknown,false
